x
|
QUARTERLY
REPORT PURSUANT TO SECTION 13 OR 15(d) OF
THE
SECURITIES EXCHANGE ACT OF 1934
|
¨
|
TRANSITION
REPORT PURSUANT TO SECTION 13 OR 15(d)
OF
THE SECURITIES EXCHANGE ACT OF 1934
|
Delaware
|
|
13-2646102
|
(State
or other jurisdiction of incorporation
or organization)
|
(I.R.S.
Employer Identification
No.)
|
Yes
|
X
|
No
|
Large
accelerated filer
|
X
|
Accelerated
filer
|
Non-accelerated
filer
|
Yes
|
No
|
X
|
Class
|
Outstanding
at April 20, 2007
|
|
Common
stock, $0.01 par value
|
537,027,337
shares
|
|
Carolina
Group stock, $0.01 par value
|
108,438,523
shares
|
Page
|
|
No.
|
|
Part
I. Financial Information
|
|
Item
1. Financial Statements (unaudited)
|
|
Consolidated
Condensed Balance Sheets
|
|
March
31, 2007 and December 31, 2006
|
3
|
Consolidated
Condensed Statements of Income
|
|
Three
months ended March 31, 2007 and 2006
|
4
|
Consolidated
Condensed Statements of Shareholders’ Equity
|
|
March
31, 2007 and 2006
|
5
|
Consolidated
Condensed Statements of Cash Flows
|
|
Three
months ended March 31, 2007 and 2006
|
6
|
Notes
to Consolidated Condensed Financial Statements
|
8
|
Item
2. Management’s Discussion and Analysis of Financial Condition
and Results of Operations
|
47
|
Item
3. Quantitative and Qualitative Disclosures about Market
Risk
|
81
|
Item
4. Controls and Procedures
|
84
|
Part
II. Other Information
|
|
Item
1. Legal Proceedings
|
85
|
Item
1A. Risk Factors
|
85
|
Item
2. Unregistered Sales of Equity Securities and Use of
Proceeds
|
85
|
Item
6. Exhibits
|
86
|
March
31,
|
December
31,
|
||||||
2007
|
2006
|
||||||
(In
millions)
|
|||||||
Assets:
|
|||||||
Investments:
|
|||||||
Fixed
maturities, amortized cost of $34,409.3 and $36,852.6
|
$
|
35,146.6
|
$
|
37,569.7
|
|||
Equity
securities, cost of $1,028.6 and $967.0
|
1,359.0
|
1,308.8
|
|||||
Limited
partnership investments
|
2,268.1
|
2,160.5
|
|||||
Other
investments
|
26.6
|
27.4
|
|||||
Short-term
investments
|
14,621.2
|
12,822.4
|
|||||
Total
investments
|
53,421.5
|
53,888.8
|
|||||
Cash
|
128.5
|
133.8
|
|||||
Receivables
|
13,064.0
|
13,027.3
|
|||||
Property,
plant and equipment
|
5,720.4
|
5,501.3
|
|||||
Deferred
income taxes
|
605.2
|
620.9
|
|||||
Goodwill
and other intangible assets
|
297.4
|
298.9
|
|||||
Other
assets
|
1,798.2
|
1,716.5
|
|||||
Deferred
acquisition costs of insurance subsidiaries
|
1,189.5
|
1,190.4
|
|||||
Separate
account business
|
514.9
|
503.0
|
|||||
Total
assets
|
$
|
76,739.6
|
$
|
76,880.9
|
|||
Liabilities
and Shareholders’ Equity:
|
|||||||
Insurance
reserves:
|
|||||||
Claim
and claim adjustment expense
|
$
|
29,509.9
|
$
|
29,636.0
|
|||
Future
policy benefits
|
6,754.8
|
6,644.7
|
|||||
Unearned
premiums
|
3,824.0
|
3,783.8
|
|||||
Policyholders’
funds
|
976.8
|
1,015.4
|
|||||
Total
insurance reserves
|
41,065.5
|
41,079.9
|
|||||
Payable
for securities purchased
|
1,380.6
|
1,046.7
|
|||||
Collateral
on loaned securities
|
2,914.1
|
3,601.5
|
|||||
Short-term
debt
|
4.3
|
4.6
|
|||||
Long-term
debt
|
5,128.1
|
5,567.8
|
|||||
Reinsurance
balances payable
|
576.8
|
539.1
|
|||||
Other
liabilities
|
4,832.3
|
5,140.2
|
|||||
Separate
account business
|
514.9
|
503.0
|
|||||
Total
liabilities
|
56,416.6
|
57,482.8
|
|||||
Minority
interest
|
3,405.5
|
2,896.3
|
|||||
Preferred
stock, $0.10 par value,
|
|||||||
Authorized
- 100,000,000 shares
|
|||||||
Common
stock:
|
|||||||
Loews
common stock, $0.01 par value:
|
|||||||
Authorized
- 1,800,000,000 shares
|
|||||||
Issued
- 544,282,036 and 544,203,457 shares
|
5.4
|
5.4
|
|||||
Carolina
Group stock, $0.01 par value:
|
|||||||
Authorized
- 600,000,000 shares
|
|||||||
Issued
-108,776,023 and 108,665,806 shares
|
1.1
|
1.1
|
|||||
Additional
paid-in capital
|
4,058.1
|
4,017.6
|
|||||
Earnings
retained in the business
|
12,780.9
|
12,098.7
|
|||||
Accumulated
other comprehensive income
|
393.7
|
386.7
|
|||||
17,239.2
|
16,509.5
|
||||||
Less
treasury stock, at cost (7,261,449 shares of Loews common stock
as
of
|
|||||||
March
31, 2007 and 340,000 shares of Carolina Group stock as of
|
|||||||
March
31, 2007 and December 31, 2006)
|
321.7
|
7.7
|
|||||
Total
shareholders’ equity
|
16,917.5
|
16,501.8
|
|||||
Total
liabilities and shareholders’ equity
|
$
|
76,739.6
|
$
|
76,880.9
|
Three
Months Ended March 31
|
2007
|
2006
|
|||||
(In
millions, except per share data)
|
|||||||
Revenues:
|
|||||||
Insurance
premiums
|
$
|
1,862.3
|
$
|
1,868.6
|
|||
Net
investment income
|
765.4
|
704.1
|
|||||
Investment
gains (losses)
|
(21.3
|
)
|
2.0
|
||||
Gain
on issuance of subsidiary stock
|
135.3
|
||||||
Manufactured
products (including excise taxes of $161.7 and $163.9)
|
959.2
|
898.4
|
|||||
Other
|
958.8
|
771.4
|
|||||
Total
|
4,659.7
|
4,244.5
|
|||||
Expenses:
|
|||||||
Insurance
claims and policyholders’ benefits
|
1,447.9
|
1,492.0
|
|||||
Amortization
of deferred acquisition costs
|
380.9
|
370.2
|
|||||
Cost
of manufactured products sold
|
567.5
|
533.3
|
|||||
Other
operating expenses
|
797.5
|
789.8
|
|||||
Interest
|
78.6
|
74.6
|
|||||
Total
|
3,272.4
|
3,259.9
|
|||||
1,387.3
|
984.6
|
||||||
Income
tax expense
|
455.3
|
334.2
|
|||||
Minority
interest
|
165.9
|
104.4
|
|||||
Total
|
621.2
|
438.6
|
|||||
Income
from continuing operations
|
766.1
|
546.0
|
|||||
Discontinued
operations, net
|
2.2
|
(5.0
|
)
|
||||
Net
income
|
$
|
768.3
|
$
|
541.0
|
|||
Net
income attributable to:
|
|||||||
Loews
common stock:
|
|||||||
Income
from continuing operations
|
$
|
648.5
|
$
|
478.4
|
|||
Discontinued
operations, net
|
2.2
|
(5.0
|
)
|
||||
Loews
common stock
|
650.7
|
473.4
|
|||||
Carolina
Group stock
|
117.6
|
67.6
|
|||||
Total
|
$
|
768.3
|
$
|
541.0
|
Basic
and diluted net income per Loews common share
|
|||||||
Income
from continuing operations
|
$
|
1.20
|
$
|
0.86
|
|||
Discontinued
operations, net
|
(0.01
|
)
|
|||||
Net
income
|
$
|
1.20
|
$
|
0.85
|
|||
Basic
net income per Carolina Group share
|
$
|
1.09
|
$
|
0.86
|
|||
Diluted
net income per Carolina Group share
|
$
|
1.08
|
$
|
0.86
|
|||
Basic
weighted average number of shares outstanding:
|
|||||||
Loews
common stock
|
541.52
|
557.47
|
|||||
Carolina
Group stock
|
108.38
|
78.23
|
|||||
Diluted
weighted average number of shares outstanding:
|
|||||||
Loews
common stock
|
542.56
|
558.24
|
|||||
Carolina
Group stock
|
108.51
|
78.33
|
Comprehensive
Income
(Loss)
|
Loews
Common
Stock
|
Carolina
Group
Stock
|
Additional
Paid-in
Capital
|
Earnings
Retained
in
the
Business
|
Accumulated
Other
Comprehensive
Income
|
Common
Stock
Held
in
Treasury
|
||||||||||||||||
(In
millions, except per share data)
|
||||||||||||||||||||||
Balance,
January 1, 2006
|
$
|
5.6
|
$
|
0.8
|
$
|
2,417.9
|
$
|
10,364.4
|
$
|
311.1
|
$
|
(7.7
|
)
|
|||||||||
Comprehensive
income:
|
||||||||||||||||||||||
Net
income
|
$
|
541.0
|
541.0
|
|||||||||||||||||||
Other
comprehensive losses
|
(217.3
|
)
|
(217.3
|
)
|
||||||||||||||||||
Comprehensive
income
|
$
|
323.7
|
||||||||||||||||||||
Dividends
paid:
|
||||||||||||||||||||||
Loews
common stock, $0.05
|
||||||||||||||||||||||
per
share
|
(27.9
|
)
|
||||||||||||||||||||
Carolina
Group stock, $0.455
|
||||||||||||||||||||||
per
share
|
(35.6
|
)
|
||||||||||||||||||||
Purchase
of Loews treasury stock
|
(55.7
|
)
|
||||||||||||||||||||
Issuance
of Loews common stock
|
8.2
|
|||||||||||||||||||||
Issuance
of Carolina Group
stock
|
2.3
|
|||||||||||||||||||||
Stock-based
compensation
|
2.3
|
|||||||||||||||||||||
Other
|
1.1
|
|||||||||||||||||||||
Balance,
March 31, 2006
|
$
|
5.6
|
$
|
0.8
|
$
|
2,431.8
|
$
|
10,841.9
|
$
|
93.8
|
$
|
(63.4
|
)
|
|||||||||
|
||||||||||||||||||||||
Balance, January 1, 2007 | $ | 5.4 | $ | 1.1 | $ | 4,017.6 | $ | 12,098.7 | $ | 386.7 | $ | (7.7 | ) | |||||||||
Adjustment
to initially apply:
|
||||||||||||||||||||||
FIN
No. 48 (Note 13)
|
(36.6
|
)
|
||||||||||||||||||||
FSP
FTB 85-4-1 (Note 1)
|
33.7
|
|||||||||||||||||||||
Balance,
January 1, 2007, as adjusted
|
5.4
|
1.1
|
4,017.6
|
12,095.8
|
386.7
|
(7.7
|
)
|
|||||||||||||||
Comprehensive
income:
|
||||||||||||||||||||||
Net
income
|
$
|
768.3
|
768.3
|
|||||||||||||||||||
Other
comprehensive income
|
7.0
|
7.0
|
||||||||||||||||||||
Comprehensive
income
|
$
|
775.3
|
||||||||||||||||||||
Dividends
paid:
|
||||||||||||||||||||||
Loews
common stock, $0.063
|
||||||||||||||||||||||
per
share
|
(33.9
|
)
|
||||||||||||||||||||
Carolina
Group stock, $0.455
|
||||||||||||||||||||||
per
share
|
(49.3
|
)
|
||||||||||||||||||||
Purchase
of Loews treasury stock
|
(314.0
|
)
|
||||||||||||||||||||
Issuance
of Loews common stock
|
2.1
|
|||||||||||||||||||||
Issuance
of Carolina Group
stock
|
2.9
|
|||||||||||||||||||||
Stock-based
compensation
|
7.9
|
|||||||||||||||||||||
Other
|
1.9
|
|||||||||||||||||||||
Deferred
tax benefit related to
|
||||||||||||||||||||||
interest
expense imputed on
|
||||||||||||||||||||||
Diamond
Offshore’s 1.5%
|
||||||||||||||||||||||
debentures
(Note 7)
|
25.7
|
|||||||||||||||||||||
Balance,
March 31, 2007
|
$
|
5.4
|
$
|
1.1
|
$
|
4,058.1
|
$
|
12,780.9
|
$
|
393.7
|
$
|
(321.7
|
)
|
Three
Months Ended March 31
|
2007
|
2006
|
|||||
(In
millions)
|
|||||||
Operating
Activities:
|
|||||||
Net
income
|
$
|
768.3
|
$
|
541.0
|
|||
Adjustments
to reconcile net income to net cash
|
|||||||
provided
(used) by operating activities, net
|
103.5
|
187.1
|
|||||
Changes
in operating assets and liabilities, net:
|
|||||||
Reinsurance
receivables
|
105.4
|
273.5
|
|||||
Other
receivables
|
(27.8
|
)
|
(67.8
|
)
|
|||
Federal
income tax
|
273.1
|
109.1
|
|||||
Prepaid
reinsurance premiums
|
(30.5
|
)
|
(100.3
|
)
|
|||
Deferred
acquisition costs
|
0.9
|
(0.9
|
)
|
||||
Insurance
reserves and claims
|
30.8
|
(181.5
|
)
|
||||
Reinsurance
balances payable
|
37.7
|
(16.9
|
)
|
||||
Other
liabilities
|
(578.4
|
)
|
(396.8
|
)
|
|||
Trading
securities
|
(639.9
|
)
|
229.9
|
||||
Other,
net
|
(31.4
|
)
|
87.1
|
||||
Net
cash flow operating activities - continuing operations
|
11.7
|
663.5
|
|||||
Net
cash flow operating activities - discontinued operations
|
(17.9
|
)
|
(4.6
|
)
|
|||
Net
cash flow operating activities - total
|
(6.2
|
)
|
658.9
|
||||
Investing
Activities:
|
|||||||
Purchases
of fixed maturities
|
(15,551.7
|
)
|
(14,860.8
|
)
|
|||
Proceeds
from sales of fixed maturities
|
16,435.1
|
16,338.5
|
|||||
Proceeds
from maturities of fixed maturities
|
1,016.4
|
1,103.8
|
|||||
Purchases
of equity securities
|
(70.6
|
)
|
(596.5
|
)
|
|||
Proceeds
from sales of equity securities
|
69.3
|
581.6
|
|||||
Purchases
of property and equipment
|
(324.1
|
)
|
(199.9
|
)
|
|||
Proceeds
from sales of property and equipment
|
0.7
|
0.5
|
|||||
Change
in collateral on loaned securities
|
(687.4
|
)
|
1,022.0
|
||||
Change
in short-term investments
|
(420.9
|
)
|
(3,373.9
|
)
|
|||
Change
in other investments
|
(34.4
|
)
|
(114.2
|
)
|
|||
Other,
net
|
(34.8
|
)
|
|||||
Net
cash flow investing activities - continuing operations
|
397.6
|
(98.9
|
)
|
||||
Net
cash flow investing activities - discontinued operations
|
0.6
|
(3.5
|
)
|
||||
Net
cash flow investing activities - total
|
398.2
|
(102.4
|
)
|
Three
Months Ended March 31
|
2007
|
2006
|
|||||
(In
millions)
|
|||||||
Financing
Activities:
|
|||||||
Dividends
paid
|
$
|
(83.2
|
)
|
$
|
(63.5
|
)
|
|
Dividends
paid to minority interest
|
(290.6
|
)
|
(98.5
|
)
|
|||
Purchases
of treasury shares
|
(314.0
|
)
|
(55.7
|
)
|
|||
Issuance
of common stock
|
4.3
|
8.1
|
|||||
Proceeds
from subsidiaries’
equity
issuances
|
307.6
|
0.8
|
|||||
Principal
payments on debt
|
(1.0
|
)
|
(43.0
|
)
|
|||
Receipts
of investment contract account balances
|
1.4
|
0.8
|
|||||
Return
of investment contract account balances
|
(45.8
|
)
|
(344.1
|
)
|
|||
Excess
tax benefits from share-based payment arrangements
|
4.2
|
2.5
|
|||||
Other
|
2.8
|
||||||
Net
cash flow financing activities - continuing operations
|
(414.3
|
)
|
(592.6
|
)
|
|||
Net
change in cash
|
(22.3
|
)
|
(36.1
|
)
|
|||
Net
cash transactions from:
|
|||||||
Continuing
operations to discontinued operations
|
(0.4
|
)
|
15.9
|
||||
Discontinued
operations to continuing operations
|
0.4
|
(15.9
|
)
|
||||
Cash,
beginning of period
|
174.0
|
182.0
|
|||||
Cash,
end of period
|
$
|
151.7
|
$
|
145.9
|
|||
Cash,
end of period:
|
|||||||
Continuing
operations
|
$
|
128.5
|
$
|
141.0
|
|||
Discontinued
operations
|
23.2
|
4.9
|
|||||
Total
|
$
|
151.7
|
$
|
145.9
|
As
of March 31, 2007
|
Number
of Life
Settlement
Contracts
|
Fair
Value of Life
Settlement
Contracts
|
Face Amount of
Life
Insurance
Policies
|
|||||||
(In
millions of dollars)
|
||||||||||
Estimated
maturity during:
|
||||||||||
2007
|
60
|
$
|
6.0
|
$
|
38.0
|
|||||
2008
|
80
|
8.0
|
50.0
|
|||||||
2009
|
80
|
8.0
|
49.0
|
|||||||
2010
|
80
|
8.0
|
49.0
|
|||||||
2011
|
80
|
9.0
|
51.0
|
|||||||
Thereafter
|
1,075
|
69.0
|
538.0
|
|||||||
Total
|
1,455
|
$
|
108.0
|
$
|
775.0
|
Three
Months Ended March 31
|
2007
|
2006
|
|||||
(In
millions)
|
|||||||
Net
investment income consisted of:
|
|||||||
Fixed
maturities
|
$
|
496.4
|
$
|
421.3
|
|||
Short-term
investments
|
96.2
|
95.3
|
|||||
Limited
partnerships
|
63.0
|
80.1
|
|||||
Equity
securities
|
5.1
|
7.9
|
|||||
Income
from trading portfolio
|
91.4
|
112.9
|
|||||
Interest
expense on funds withheld and other deposits
|
(0.5
|
)
|
(24.8
|
)
|
|||
Other
|
21.7
|
23.5
|
|||||
Total
investment income
|
773.3
|
716.2
|
|||||
Investment
expense
|
(7.9
|
)
|
(12.1
|
)
|
|||
Net
investment income
|
$
|
765.4
|
$
|
704.1
|
Three
Months Ended March 31
|
2007
|
2006
|
|||||
(In
millions)
|
|||||||
Investment
gains (losses) are as follows:
|
|||||||
Fixed
maturities
|
$
|
(17.4
|
)
|
$
|
(10.1
|
)
|
|
Equity
securities, including short positions
|
3.5
|
7.0
|
|||||
Derivative
instruments
|
(7.7
|
)
|
6.9
|
||||
Short-term
investments
|
(0.1
|
)
|
(2.5
|
)
|
|||
Other,
including guaranteed separate account business
|
0.4
|
0.7
|
|||||
Investment
gains (losses)
|
(21.3
|
)
|
2.0
|
||||
Gain
on issuance of subsidiary stock (Note 7)
|
135.3
|
||||||
114.0
|
2.0
|
||||||
Income
tax expense
|
(40.6
|
)
|
(5.9
|
)
|
|||
Minority
interest
|
1.6
|
0.1
|
|||||
Investment
gains (losses), net
|
$
|
75.0
|
$
|
(3.8
|
)
|
Gross
Unrealized Losses
|
||||||||||||||||
March
31, 2007
|
Amortized
Cost
|
Unrealized
Gains
|
Less
Than
12
Months
|
Greater
Than
12
Months
|
Fair
Value
|
|||||||||||
(In
millions)
|
||||||||||||||||
Fixed
maturity securities:
|
||||||||||||||||
U.S.
government and obligations
|
$
|
4,531.1
|
$
|
106.5
|
$
|
0.8
|
$
|
1.5
|
$
|
4,635.3
|
||||||
of
government agencies
|
||||||||||||||||
Asset-backed
securities
|
12,606.0
|
32.0
|
23.9
|
128.4
|
12,485.7
|
|||||||||||
States,
municipalities and political
|
||||||||||||||||
subdivisions-tax
exempt
|
5,450.6
|
221.6
|
2.5
|
4.6
|
5,665.1
|
|||||||||||
Corporate
|
6,707.7
|
307.0
|
3.3
|
8.5
|
7,002.9
|
|||||||||||
Other
debt
|
3,496.5
|
208.6
|
4.1
|
3.2
|
3,697.8
|
|||||||||||
Redeemable
preferred stocks
|
994.2
|
38.8
|
1,033.0
|
|||||||||||||
Fixed
maturities available-for-sale
|
33,786.1
|
914.5
|
34.6
|
146.2
|
34,519.8
|
|||||||||||
Fixed
maturities, trading
|
623.2
|
6.9
|
1.6
|
1.7
|
626.8
|
|||||||||||
Total
fixed maturities
|
34,409.3
|
921.4
|
36.2
|
147.9
|
35,146.6
|
|||||||||||
Equity
securities:
|
||||||||||||||||
Equity
securities available-for-sale
|
351.3
|
256.4
|
0.4
|
0.2
|
607.1
|
|||||||||||
Equity
securities, trading
|
677.3
|
96.9
|
15.6
|
6.7
|
751.9
|
|||||||||||
Total
equity securities
|
1,028.6
|
353.3
|
16.0
|
6.9
|
1,359.0
|
|||||||||||
Short-term
investments:
|
||||||||||||||||
Short-term
investments available-for-
|
||||||||||||||||
sale
|
10,138.3
|
1.3
|
0.1
|
10,139.5
|
||||||||||||
Short-term
investments, trading
|
4,481.7
|
4,481.7
|
||||||||||||||
Total
short-term investments
|
14,620.0
|
1.3
|
0.1
|
-
|
14,621.2
|
|||||||||||
Total
|
$
|
50,057.9
|
$
|
1,276.0
|
$
|
52.3
|
$
|
154.8
|
$
|
51,126.8
|
December
31, 2006
|
||||||||||||||||
Fixed
maturity securities:
|
||||||||||||||||
U.S.
government and obligations of
|
||||||||||||||||
government
agencies
|
$
|
5,055.6
|
$
|
86.2
|
$
|
2.6
|
$
|
1.6
|
$
|
5,137.6
|
||||||
Asset-backed
securities
|
13,822.8
|
27.7
|
20.8
|
151.0
|
13,678.7
|
|||||||||||
States,
municipalities and political
|
||||||||||||||||
subdivisions-tax
exempt
|
4,915.2
|
236.9
|
1.2
|
4.6
|
5,146.3
|
|||||||||||
Corporate
|
6,810.8
|
337.8
|
7.5
|
9.7
|
7,131.4
|
|||||||||||
Other
debt
|
3,442.7
|
207.6
|
6.6
|
2.0
|
3,641.7
|
|||||||||||
Redeemable
preferred stocks
|
885.0
|
27.8
|
0.5
|
912.3
|
||||||||||||
Fixed
maturities available-for-sale
|
34,932.1
|
924.0
|
39.2
|
168.9
|
35,648.0
|
|||||||||||
Fixed
maturities, trading
|
1,920.5
|
6.0
|
4.4
|
0.4
|
1,921.7
|
|||||||||||
Total
fixed maturities
|
36,852.6
|
930.0
|
43.6
|
169.3
|
37,569.7
|
|||||||||||
Equity
securities:
|
||||||||||||||||
Equity
securities available-for-sale
|
348.4
|
249.0
|
0.2
|
0.2
|
597.0
|
|||||||||||
Equity
securities, trading
|
618.6
|
111.6
|
10.4
|
8.0
|
711.8
|
|||||||||||
Total
equity securities
|
967.0
|
360.6
|
10.6
|
8.2
|
1,308.8
|
|||||||||||
Short-term
investments:
|
||||||||||||||||
Short-term
investments available-for-
|
||||||||||||||||
sale
|
8,436.9
|
8,436.9
|
||||||||||||||
Short-term
investments, trading
|
4,385.2
|
0.4
|
0.1
|
4,385.5
|
||||||||||||
Total
short-term investments
|
12,822.1
|
0.4
|
0.1
|
−
|
12,822.4
|
|||||||||||
Total
|
$
|
50,641.7
|
$
|
1,291.0
|
$
|
54.3
|
$
|
177.5
|
$
|
51,700.9
|
March
31, 2007
|
December
31, 2006
|
||||||||||||
Estimated
Fair
Value
|
Gross
Unrealized
Loss
|
Estimated
Fair
Value
|
Gross
Unrealized
Loss
|
||||||||||
(In
millions)
|
|||||||||||||
Fixed
maturity securities:
|
|||||||||||||
Investment
grade:
|
|||||||||||||
0-6
months
|
$
|
3,380.7
|
$
|
27.3
|
$
|
9,829.3
|
$
|
23.7
|
|||||
7-12
months
|
459.3
|
5.7
|
1,267.1
|
11.8
|
|||||||||
13-24
months
|
4,795.5
|
92.0
|
5,247.9
|
127.4
|
|||||||||
Greater
than 24 months
|
1,679.1
|
53.9
|
1,021.4
|
41.1
|
|||||||||
Total
investment grade
|
10,314.6
|
178.9
|
17,365.7
|
204.0
|
|||||||||
Non-investment
grade:
|
|||||||||||||
0-6
months
|
143.0
|
0.5
|
509.0
|
2.1
|
|||||||||
7-12
months
|
29.9
|
1.2
|
87.3
|
1.5
|
|||||||||
13-24
months
|
6.7
|
0.2
|
23.9
|
0.5
|
|||||||||
Greater
than 24 months
|
2.3
|
2.3
|
|||||||||||
Total
non-investment grade
|
181.9
|
1.9
|
622.5
|
4.1
|
|||||||||
Total
fixed maturity securities
|
10,496.5
|
180.8
|
17,988.2
|
208.1
|
|||||||||
Equity
securities:
|
|||||||||||||
0-6
months
|
19.6
|
0.4
|
9.8
|
0.2
|
|||||||||
7-12
months
|
0.7
|
||||||||||||
13-24
months
|
|||||||||||||
Greater
than 24 months
|
2.9
|
0.2
|
2.9
|
0.2
|
|||||||||
Total
equity securities
|
22.5
|
0.6
|
13.4
|
0.4
|
|||||||||
Total
fixed maturity and equity securities
|
$
|
10,519.0
|
$
|
181.4
|
$
|
18,001.6
|
$
|
208.5
|
Three
Months Ended March 31
|
2007
|
2006
|
|||||
(In
millions, except %)
|
|||||||
Loews
common stock:
|
|||||||
Consolidated
net income
|
$
|
768.3
|
$
|
541.0
|
|||
Less
income attributable to Carolina Group stock
|
117.6
|
67.6
|
|||||
Income
attributable to Loews common stock
|
$
|
650.7
|
$
|
473.4
|
|||
Carolina
Group stock:
|
|||||||
Income
available to Carolina Group stock
|
$
|
188.7
|
$
|
150.1
|
|||
Weighted
average economic interest of the Carolina Group
|
62.4
|
%
|
45.0
|
%
|
|||
Income
attributable to Carolina Group stock
|
$
|
117.6
|
$
|
67.6
|
Three
Months Ended March 31
|
2007
|
2006
|
|||||
(In
millions)
|
|||||||
Weighted
average shares outstanding, basic
|
108.38
|
78.23
|
|||||
Stock
based compensation awards
|
0.13
|
0.10
|
|||||
Weighted
average shares outstanding, diluted
|
108.51
|
78.33
|
Three
Months Ended March 31
|
2007
|
2006
|
|||||
Loews
common stock
|
2,779
|
151,880
|
|||||
Carolina
Group stock
|
556
|
567
|
Adjustments
|
|||||||||||||||||||
Carolina
Group
|
Loews
|
and
|
|||||||||||||||||
March
31, 2007
|
Lorillard
|
Other
|
Consolidated
|
Group
|
Eliminations
|
Total
|
|||||||||||||
(In
millions)
|
|||||||||||||||||||
Assets:
|
|||||||||||||||||||
Investments
|
$
|
1,448.4
|
$
|
100.7
|
$
|
1,549.1
|
$
|
51,872.4
|
$
|
53,421.5
|
|||||||||
Cash
|
0.8
|
0.9
|
1.7
|
126.8
|
128.5
|
||||||||||||||
Receivables
|
18.1
|
0.1
|
18.2
|
13,060.7
|
$
|
(14.9
|
) (a)
|
13,064.0
|
|||||||||||
Property,
plant and
|
|||||||||||||||||||
equipment
|
200.0
|
200.0
|
5,520.4
|
5,720.4
|
|||||||||||||||
Deferred
income taxes
|
519.3
|
519.3
|
85.9
|
605.2
|
|||||||||||||||
Goodwill
and other intangible
|
|||||||||||||||||||
assets
|
297.4
|
297.4
|
|||||||||||||||||
Other
assets
|
326.7
|
326.7
|
1,471.5
|
1,798.2
|
|||||||||||||||
Investment
in combined
|
|||||||||||||||||||
attributed
net assets of the
|
|||||||||||||||||||
Carolina
Group
|
1,179.1
|
(1,088.0
|
)
(a)
|
||||||||||||||||
|
(91.1 | ) (b) | |||||||||||||||||
Deferred
acquisition costs of
|
|||||||||||||||||||
insurance
subsidiaries
|
1,189.5
|
1,189.5
|
|||||||||||||||||
Separate
account business
|
514.9
|
514.9
|
|||||||||||||||||
Total
assets
|
$
|
2,513.3
|
$
|
101.7
|
$
|
2,615.0
|
$
|
75,318.6
|
$
|
(1,194.0
|
)
|
$
|
76,739.6
|
||||||
Liabilities
and Shareholders’ Equity:
|
|||||||||||||||||||
Insurance
reserves
|
$
|
41,065.5
|
$
|
41,065.5
|
|||||||||||||||
Payable
for securities
|
|||||||||||||||||||
purchased
|
1,380.6
|
1,380.6
|
|||||||||||||||||
Collateral
on loaned securities
|
2,914.1
|
2,914.1
|
|||||||||||||||||
Short-term
debt
|
4.3
|
4.3
|
|||||||||||||||||
Long-term
debt
|
$
|
1,088.0
|
$
|
1,088.0
|
5,128.1
|
$
|
(1,088.0
|
)
(a)
|
5,128.1
|
||||||||||
Reinsurance
balances payable
|
576.8
|
576.8
|
|||||||||||||||||
Other
liabilities
|
$
|
1,274.4
|
10.6
|
1,285.0
|
3,562.2
|
(14.9
|
)
(a)
|
4,832.3
|
|||||||||||
Separate
account business
|
514.9
|
514.9
|
|||||||||||||||||
Total
liabilities
|
1,274.4
|
1,098.6
|
2,373.0
|
55,146.5
|
(1,102.9
|
)
|
56,416.6
|
||||||||||||
Minority
interest
|
3,405.5
|
3,405.5
|
|||||||||||||||||
Shareholders’
equity
|
1,238.9
|
(996.9
|
)
|
242.0
|
16,766.6
|
(91.1
|
)
(b)
|
16,917.5
|
|||||||||||
Total
liabilities and
|
|||||||||||||||||||
shareholders’
equity
|
$
|
2,513.3
|
$
|
101.7
|
$
|
2,615.0
|
$
|
75,318.6
|
$
|
(1,194.0
|
)
|
$
|
76,739.6
|
(a)
|
To
eliminate the intergroup notional debt and interest
payable/receivable.
|
(b)
|
To
eliminate the Loews Group’s 37.6% equity interest in the combined
attributed net assets of the Carolina
Group.
|
Adjustments
|
|
||||||||||||||||||
Carolina
Group
|
Loews
|
and
|
|
||||||||||||||||
December
31, 2006
|
Lorillard
|
Other
|
Consolidated
|
Group
|
Eliminations
|
|
Total
|
||||||||||||
(In
millions)
|
|
||||||||||||||||||
|
|||||||||||||||||||
Assets:
|
|
||||||||||||||||||
|
|||||||||||||||||||
Investments
|
$
|
1,767.5
|
$
|
101.0
|
$
|
1,868.5
|
$
|
52,020.3
|
|
$
|
53,888.8
|
||||||||
Cash
|
1.2
|
0.3
|
1.5
|
132.3
|
|
133.8
|
|||||||||||||
Receivables
|
15.6
|
0.4
|
16.0
|
13,028.2
|
$
|
(16.9
|
) (a)
|
13,027.3
|
|||||||||||
Property,
plant and
|
|||||||||||||||||||
equipment
|
196.4
|
196.4
|
5,304.9
|
5,501.3
|
|||||||||||||||
Deferred
income taxes
|
495.7
|
495.7
|
125.2
|
|
620.9
|
||||||||||||||
Goodwill
and other intangible
|
|
||||||||||||||||||
assets
|
298.9
|
|
298.9
|
||||||||||||||||
Other
assets
|
282.8
|
282.8
|
1,433.7
|
|
1,716.5
|
||||||||||||||
Investment
in combined
|
|
||||||||||||||||||
attributed
net assets of the
|
1,288.3
|
(1,229.7
|
)
(a)
|
||||||||||||||||
Carolina
Group
|
(58.6
|
)
(b)
|
|||||||||||||||||
|
|||||||||||||||||||
Deferred
acquisition costs of
|
|
||||||||||||||||||
insurance
subsidiaries
|
1,190.4
|
|
1,190.4
|
||||||||||||||||
Separate
account business
|
503.0
|
503.0
|
|||||||||||||||||
Total
assets
|
$
|
2,759.2
|
$
|
101.7
|
$
|
2,860.9
|
$
|
75,325.2
|
$
|
(1,305.2
|
)
|
$
|
76,880.9
|
||||||
|
|||||||||||||||||||
Liabilities
and Shareholders’ Equity:
|
|
||||||||||||||||||
|
|||||||||||||||||||
Insurance
reserves
|
$
|
41,079.9
|
|
$
|
41,079.9
|
||||||||||||||
Payable
for securities
|
|
||||||||||||||||||
purchased
|
1,046.7
|
|
1,046.7
|
||||||||||||||||
Collateral
on loaned securities
|
3,601.5
|
|
3,601.5
|
||||||||||||||||
Short-term
debt
|
4.6
|
|
4.6
|
||||||||||||||||
Long-term
debt
|
$
|
1,229.7
|
$
|
1,229.7
|
5,567.8
|
$
|
(1,229.7
|
)
(a)
|
5,567.8
|
||||||||||
Reinsurance
balances payable
|
539.1
|
|
539.1
|
||||||||||||||||
Other
liabilities
|
$
|
1,463.9
|
11.5
|
1,475.4
|
3,681.7
|
(16.9
|
)
(a)
|
5,140.2
|
|||||||||||
Separate
account business
|
503.0
|
|
503.0
|
||||||||||||||||
Total
liabilities
|
1,463.9
|
1,241.2
|
2,705.1
|
56,024.3
|
(1,246.6
|
)
|
57,482.8
|
||||||||||||
Minority
interest
|
2,896.3
|
|
2,896.3
|
||||||||||||||||
Shareholders’
equity
|
1,295.3
|
(1,139.5
|
)
|
155.8
|
16,404.6
|
(58.6
|
)
(b)
|
16,501.8
|
|||||||||||
Total
liabilities and
|
|
||||||||||||||||||
shareholders’
equity
|
$
|
2,759.2
|
$
|
101.7
|
$
|
2,860.9
|
$
|
75,325.2
|
$
|
(1,305.2
|
)
|
$
|
76,880.9
|
(a)
|
To
eliminate the intergroup notional debt and interest
payable/receivable.
|
(b)
|
To
eliminate the Loews Group’s 37.7% equity interest in the combined
attributed net assets of the Carolina
Group.
|
Adjustments
|
|||||||||||||||||||
Three
Months Ended
|
Carolina
Group
|
Loews
|
and
|
||||||||||||||||
March
31, 2007
|
Lorillard
|
Other
|
Consolidated
|
Group
|
Eliminations
|
Total
|
|||||||||||||
(In
millions)
|
|||||||||||||||||||
Revenues:
|
|||||||||||||||||||
Insurance
premiums
|
$
|
1,862.3
|
$
|
1,862.3
|
|||||||||||||||
Net
investment income
|
$
|
31.5
|
$
|
2.3
|
$
|
33.8
|
754.8
|
$
|
(23.2
|
)
(a)
|
765.4
|
||||||||
Investment
gains (losses)
|
0.1
|
0.1
|
(21.4
|
)
|
(21.3
|
)
|
|||||||||||||
Gain
on issuance of subsidiary
|
|||||||||||||||||||
stock
|
135.3
|
135.3
|
|||||||||||||||||
Manufactured
products
|
913.0
|
913.0
|
46.2
|
959.2
|
|||||||||||||||
Other
|
0.4
|
0.4
|
958.4
|
958.8
|
|||||||||||||||
Total
|
945.0
|
2.3
|
947.3
|
3,735.6
|
(23.2
|
)
|
4,659.7
|
||||||||||||
Expenses:
|
|||||||||||||||||||
Insurance
claims and
|
|||||||||||||||||||
policyholders’
benefits
|
1,447.9
|
1,447.9
|
|||||||||||||||||
Amortization
of deferred
|
|||||||||||||||||||
acquisition
costs
|
380.9
|
380.9
|
|||||||||||||||||
Cost
of manufactured products
|
|||||||||||||||||||
sold
|
544.3
|
544.3
|
23.2
|
567.5
|
|||||||||||||||
Other
operating expenses
|
81.8
|
0.1
|
81.9
|
715.6
|
797.5
|
||||||||||||||
Interest
|
23.2
|
23.2
|
78.6
|
(23.2
|
)
(a)
|
78.6
|
|||||||||||||
Total
|
626.1
|
23.3
|
649.4
|
2,646.2
|
(23.2
|
)
|
3,272.4
|
||||||||||||
318.9
|
(21.0
|
)
|
297.9
|
1,089.4
|
1,387.3
|
||||||||||||||
Income
tax expense (benefit)
|
116.9
|
(7.7
|
)
|
109.2
|
346.1
|
455.3
|
|||||||||||||
Minority
interest
|
165.9
|
165.9
|
|||||||||||||||||
Total
|
116.9
|
(7.7
|
)
|
109.2
|
512.0
|
621.2
|
|||||||||||||
Income
(loss) from operations
|
202.0
|
(13.3
|
)
|
188.7
|
577.4
|
766.1
|
|||||||||||||
Equity
in earnings of the
|
|||||||||||||||||||
Carolina
Group
|
71.1
|
(71.1
|
) (b)
|
||||||||||||||||
Income
(loss) from continuing
|
|||||||||||||||||||
operations
|
202.0
|
(13.3
|
)
|
188.7
|
648.5
|
(71.1
|
)
|
766.1
|
|||||||||||
Discontinued
operations, net
|
2.2
|
2.2
|
|||||||||||||||||
Net
income (loss)
|
$
|
202.0
|
$
|
(13.3
|
)
|
$
|
188.7
|
$
|
650.7
|
$
|
(71.1
|
)
|
$
|
768.3
|
(a)
|
To
eliminate interest on the intergroup notional
debt.
|
(b)
|
To
eliminate the Loews Group’s intergroup interest in the earnings of the
Carolina Group.
|
Adjustments
|
|||||||||||||||||||
Three
Months Ended
|
Carolina
Group
|
Loews
|
and
|
||||||||||||||||
March
31, 2006
|
Lorillard
|
Other
|
Consolidated
|
Group
|
Eliminations
|
Total
|
|||||||||||||
(In
millions)
|
|||||||||||||||||||
Revenues:
|
|||||||||||||||||||
Insurance
premiums
|
$
|
1,868.6
|
$
|
1,868.6
|
|||||||||||||||
Net
investment income
|
$
|
24.8
|
$
|
1.8
|
$
|
26.6
|
709.0
|
$
|
(31.5
|
) (a)
|
704.1
|
||||||||
Investment
gains (losses)
|
(0.6
|
)
|
(0.6
|
)
|
2.6
|
2.0
|
|||||||||||||
Manufactured
products
|
854.8
|
854.8
|
43.6
|
898.4
|
|||||||||||||||
Other
|
771.4
|
771.4
|
|||||||||||||||||
Total
|
879.0
|
1.8
|
880.8
|
3,395.2
|
(31.5
|
)
|
4,244.5
|
||||||||||||
Expenses:
|
|||||||||||||||||||
Insurance
claims and
|
|||||||||||||||||||
policyholders’
benefits
|
1,492.0
|
1,492.0
|
|||||||||||||||||
Amortization
of deferred
|
|||||||||||||||||||
acquisition
costs
|
370.2
|
370.2
|
|||||||||||||||||
Cost
of manufactured products
|
|||||||||||||||||||
sold
|
511.7
|
511.7
|
21.6
|
533.3
|
|||||||||||||||
Other
operating expenses
|
92.8
|
0.1
|
92.9
|
696.9
|
789.8
|
||||||||||||||
Interest
|
31.5
|
31.5
|
74.6
|
(31.5
|
)(a)
|
74.6
|
|||||||||||||
Total
|
604.5
|
31.6
|
636.1
|
2,655.3
|
(31.5
|
)
|
3,259.9
|
||||||||||||
274.5
|
(29.8
|
)
|
244.7
|
739.9
|
-
|
984.6
|
|||||||||||||
Income
tax expense (benefit)
|
106.1
|
(11.5
|
)
|
94.6
|
239.6
|
334.2
|
|||||||||||||
Minority
interest
|
104.4
|
104.4
|
|||||||||||||||||
Total
|
106.1
|
(11.5
|
)
|
94.6
|
344.0
|
-
|
438.6
|
||||||||||||
Income
(loss) from operations
|
168.4
|
(18.3
|
)
|
150.1
|
395.9
|
-
|
546.0
|
||||||||||||
Equity
in earnings of the
|
|||||||||||||||||||
Carolina
Group
|
82.5
|
(82.5
|
)
(b)
|
||||||||||||||||
Income
(loss) from continuing
|
|||||||||||||||||||
operations
|
168.4
|
(18.3
|
)
|
150.1
|
478.4
|
(82.5
|
)
|
546.0
|
|||||||||||
Discontinued
operations, net
|
(5.0
|
)
|
(5.0
|
)
|
|||||||||||||||
Net
income (loss)
|
$
|
168.4
|
$
|
(18.3
|
)
|
$
|
150.1
|
$
|
473.4
|
$
|
(82.5
|
)
|
$
|
541.0
|
(a)
|
To
eliminate interest on the intergroup notional
debt.
|
(b)
|
To
eliminate the Loews Group’s intergroup interest in the earnings of the
Carolina Group.
|
Adjustments
|
|||||||||||||||||||
Three
Months Ended
|
Carolina
Group
|
Loews
|
and
|
||||||||||||||||
March
31, 2007
|
Lorillard
|
Other
|
Consolidated
|
Group
|
Eliminations
|
Total
|
|||||||||||||
(In
millions)
|
|||||||||||||||||||
Net
cash (used) provided by
|
|||||||||||||||||||
operating
activities
|
$
|
(93.2
|
)
|
$
|
(13.9
|
)
|
$
|
(107.1
|
)
|
$
|
130.7
|
$
|
(29.8
|
)
|
$
|
(6.2
|
)
|
||
Investing
activities:
|
|||||||||||||||||||
Purchases
of property and
|
|||||||||||||||||||
equipment
|
(13.8
|
)
|
(13.8
|
)
|
(310.3
|
)
|
(324.1
|
)
|
|||||||||||
Change
in short-term
|
|||||||||||||||||||
investments
|
607.9
|
0.3
|
608.2
|
(1,029.1
|
)
|
(420.9
|
)
|
||||||||||||
Other
investing activities
|
(267.6
|
)
|
(267.6
|
)
|
1,552.5
|
(141.7
|
)
|
1,143.2
|
|||||||||||
326.5
|
0.3
|
326.8
|
213.1
|
(141.7
|
)
|
398.2
|
|||||||||||||
Financing
activities:
|
|||||||||||||||||||
Dividends
paid
|
(235.0
|
)
|
155.9
|
(79.1
|
)
|
(33.9
|
)
|
29.8
|
(83.2
|
)
|
|||||||||
Reduction
of intergroup
|
|||||||||||||||||||
notional
debt
|
(141.7
|
)
|
(141.7
|
)
|
141.7
|
||||||||||||||
Excess
tax benefits from
|
|||||||||||||||||||
share
based compensation
|
1.3
|
1.3
|
2.9
|
4.2
|
|||||||||||||||
Other
financing activities
|
(335.3
|
)
|
(335.3
|
)
|
|||||||||||||||
(233.7
|
)
|
14.2
|
(219.5
|
)
|
(366.3
|
)
|
171.5
|
(414.3
|
)
|
||||||||||
Net
change in cash
|
(0.4
|
)
|
0.6
|
0.2
|
(22.5
|
)
|
(22.3
|
)
|
|||||||||||
Net
cash transactions from:
|
|||||||||||||||||||
Continuing
operations to
|
|||||||||||||||||||
discontinued
operations
|
(0.4
|
)
|
(0.4
|
)
|
|||||||||||||||
Discontinued
operations to
|
|||||||||||||||||||
continuing
operations
|
0.4
|
0.4
|
|||||||||||||||||
Cash,
beginning of period
|
1.2
|
0.3
|
1.5
|
172.5
|
174.0
|
||||||||||||||
Cash,
end of period
|
$
|
0.8
|
$
|
0.9
|
$
|
1.7
|
$
|
150.0
|
$
|
-
|
$
|
151.7
|
Adjustments
|
|||||||||||||||||||
Three
Months Ended
|
Carolina
Group
|
Loews
|
and
|
||||||||||||||||
March
31, 2006
|
Lorillard
|
Other
|
Consolidated
|
Group
|
Eliminations
|
Total
|
|||||||||||||
(In
millions)
|
|||||||||||||||||||
Net
cash (used) provided by
|
|||||||||||||||||||
operating
activities
|
$
|
(143.4
|
)
|
$
|
(19.3
|
)
|
$
|
(162.7
|
)
|
$
|
865.0
|
$
|
(43.4
|
)
|
$
|
658.9
|
|||
Investing
activities:
|
|||||||||||||||||||
Purchases
of property and
|
|||||||||||||||||||
equipment
|
(7.8
|
)
|
(7.8
|
)
|
(192.1
|
)
|
(199.9
|
)
|
|||||||||||
Change
in short-term
|
|||||||||||||||||||
investments
|
791.9
|
0.2
|
792.1
|
(4,166.0
|
)
|
(3,373.9
|
)
|
||||||||||||
Other
investing activities
|
(442.0
|
)
|
(442.0
|
)
|
4,015.0
|
(101.6
|
)
|
3,471.4
|
|||||||||||
342.1
|
0.2
|
342.3
|
(343.1
|
)
|
(101.6
|
)
|
(102.4
|
)
|
|||||||||||
Financing
activities:
|
|||||||||||||||||||
Dividends
paid
|
(200.0
|
)
|
121.0
|
(79.0
|
)
|
(27.9
|
)
|
43.4
|
(63.5
|
)
|
|||||||||
Reduction
of intergroup
|
|||||||||||||||||||
notional
debt
|
(101.6
|
)
|
(101.6
|
)
|
101.6
|
||||||||||||||
Excess
tax benefits from
|
|||||||||||||||||||
share
based compensation
|
0.6
|
0.6
|
1.9
|
2.5
|
|||||||||||||||
Other
financing activities
|
(531.6
|
)
|
(531.6
|
)
|
|||||||||||||||
(199.4
|
)
|
19.4
|
(180.0
|
)
|
(557.6
|
)
|
145.0
|
(592.6
|
)
|
||||||||||
Net
change in cash
|
(0.7
|
)
|
0.3
|
(0.4
|
)
|
(35.7
|
)
|
(36.1
|
)
|
||||||||||
Net
cash transactions from:
|
|||||||||||||||||||
Continuing
operations to
|
|||||||||||||||||||
discontinued
operations
|
15.9
|
15.9
|
|||||||||||||||||
Discontinued
operations to
|
|||||||||||||||||||
continuing
operations
|
(15.9
|
)
|
(15.9
|
)
|
|||||||||||||||
Cash,
beginning of period
|
2.4
|
0.1
|
2.5
|
179.5
|
182.0
|
||||||||||||||
Cash,
end of period
|
$
|
1.7
|
$
|
0.4
|
$
|
2.1
|
$
|
143.8
|
$
|
-
|
$
|
145.9
|
March
31,
|
December
31,
|
||||||
2007
|
2006
|
||||||
(In
millions)
|
|||||||
Reinsurance
|
$
|
9,841.9
|
$
|
9,947.3
|
|||
Other
insurance
|
2,535.3
|
2,475.8
|
|||||
Security
sales
|
502.2
|
325.9
|
|||||
Accrued
investment income
|
330.8
|
331.4
|
|||||
Other
|
715.3
|
810.8
|
|||||
Total
|
13,925.5
|
13,891.2
|
|||||
Less: allowance
for doubtful accounts on reinsurance receivables
|
469.4
|
469.6
|
|||||
allowance for other doubtful accounts and cash discounts
|
392.1
|
394.3
|
|||||
Receivables
|
$
|
13,064.0
|
$
|
13,027.3
|
March
31, 2007
|
December
31, 2006
|
||||||||||||
Asbestos
|
Environmental
Pollution
and
Mass
Tort
|
Asbestos
|
Environmental
Pollution
and
Mass
Tort
|
||||||||||
(In
millions)
|
|||||||||||||
Gross
reserves
|
$
|
2,503.0
|
$
|
629.0
|
$
|
2,635.0
|
$
|
647.0
|
|||||
Ceded
reserves
|
(1,115.0
|
)
|
(220.0
|
)
|
(1,183.0
|
)
|
(231.0
|
)
|
|||||
Net
reserves
|
$
|
1,388.0
|
$
|
409.0
|
$
|
1,452.0
|
$
|
416.0
|
Three
Months Ended March 31, 2007
|
Standard
Lines
|
Specialty
Lines
|
Other
Insurance
|
Total
|
|||||||||
(In
millions)
|
|||||||||||||
Pretax
unfavorable net prior
|
|||||||||||||
year
claim and allocated claim adjustment
|
|||||||||||||
expense
reserve development
|
|||||||||||||
Core
(Non-APMT)
|
$
|
13.0
|
$
|
7.0
|
$ |
$
|
20.0
|
||||||
Total
unfavorable (favorable) premium
|
|||||||||||||
development
|
(27.0
|
)
|
(9.0
|
)
|
2.0
|
(34.0
|
)
|
||||||
Total
unfavorable (favorable) net prior year
|
|||||||||||||
development
(pretax)
|
$
|
(14.0
|
)
|
$
|
(2.0
|
)
|
$
|
2.0
|
$
|
(14.0
|
)
|
Three
Months Ended March 31, 2006
|
Standard
Lines
|
Specialty
Lines
|
Other
Insurance
|
Total
|
|||||||||
(In
millions)
|
|||||||||||||
Pretax
unfavorable net prior
|
|||||||||||||
year
claim and allocated claim adjustment
|
|||||||||||||
expense
reserve development
|
|||||||||||||
Core
(Non-APMT)
|
$
|
59.0
|
$
|
5.0
|
$
|
6.0
|
$
|
70.0
|
|||||
APMT
|
1.0
|
1.0
|
|||||||||||
Pretax
unfavorable net prior year development
|
|||||||||||||
before
impact of premium development
|
59.0
|
5.0
|
7.0
|
71.0
|
|||||||||
Total
unfavorable (favorable) premium development
|
(49.0
|
)
|
(8.0
|
)
|
7.0
|
(50.0
|
)
|
||||||
Total
unfavorable (favorable) net prior year
|
|||||||||||||
development
(pretax)
|
$
|
10.0
|
$
|
(3.0
|
)
|
$
|
14.0
|
$
|
21.0
|
Pension
Benefits
|
Other
Postretirement
Benefits
|
||||||||||||
Three
Months Ended March 31
|
2007
|
2006
|
2007
|
2006
|
|||||||||
(In
millions)
|
|||||||||||||
Service
cost
|
$
|
15.8
|
$
|
15.1
|
$
|
2.3
|
$
|
3.3
|
|||||
Interest
cost
|
58.0
|
54.7
|
6.5
|
8.2
|
|||||||||
Expected
return on plan assets
|
(68.0
|
)
|
(60.7
|
)
|
(1.2
|
)
|
(1.2
|
)
|
|||||
Amortization
of net loss
|
0.8
|
1.9
|
0.3
|
0.5
|
|||||||||
Amortization
of prior service cost (credit)
|
1.6
|
1.7
|
(6.8
|
)
|
(8.2
|
)
|
|||||||
Actuarial
loss
|
4.5
|
10.6
|
0.7
|
1.4
|
|||||||||
Settlement
costs
|
3.1
|
||||||||||||
Regulatory
asset decrease
|
1.4
|
3.3 | |||||||||||
Net
periodic benefit cost
|
$
|
15.8
|
$
|
23.3
|
$
|
3.2
|
$
|
7.3
|
Three
Months Ended March 31
|
2007
|
2006
|
|||||
(In
millions)
|
|||||||
Revenues
(a):
|
|||||||
CNA
Financial:
|
|||||||
Standard
Lines
|
$
|
1,314.0
|
$
|
1,347.4
|
|||
Specialty
Lines
|
789.0
|
751.3
|
|||||
Life
and Group Non-Core
|
329.9
|
350.2
|
|||||
Other
Insurance
|
84.1
|
51.6
|
|||||
Total
CNA Financial
|
2,517.0
|
2,500.5
|
|||||
Lorillard
|
944.9
|
879.6
|
|||||
Boardwalk
Pipeline
|
190.4
|
175.0
|
|||||
Diamond
Offshore
|
618.9
|
458.7
|
|||||
Loews
Hotels
|
95.3
|
93.4
|
|||||
Corporate
and other
|
293.2
|
137.3
|
|||||
Total
|
$
|
4,659.7
|
$
|
4,244.5
|
|||
Pretax
income (loss) (a):
|
|||||||
CNA
Financial:
|
|||||||
Standard
Lines
|
$
|
238.0
|
$
|
205.5
|
|||
Specialty
Lines
|
177.8
|
182.4
|
|||||
Life
and Group Non-Core
|
(7.0
|
)
|
(25.6
|
)
|
|||
Other
Insurance
|
29.2
|
(7.2
|
)
|
||||
Total
CNA Financial
|
438.0
|
355.1
|
|||||
Lorillard
|
318.8
|
275.1
|
|||||
Boardwalk
Pipeline
|
80.3
|
69.4
|
|||||
Diamond
Offshore
|
309.1
|
205.3
|
|||||
Loews
Hotels
|
17.8
|
13.9
|
|||||
Corporate
and other
|
223.3
|
65.8
|
|||||
Total
|
$
|
1,387.3
|
$
|
984.6
|
Three
Months Ended March 31
|
2007
|
2006
|
|||||
(In
millions)
|
|||||||
Net
income (loss) (a):
|
|||||||
CNA
Financial:
|
|||||||
Standard
Lines
|
$
|
142.1
|
$
|
129.8
|
|||
Specialty
Lines
|
99.3
|
105.5
|
|||||
Life
and Group Non-Core
|
2.6
|
(9.5
|
)
|
||||
Other
Insurance
|
18.6
|
(8.2
|
)
|
||||
Total
CNA Financial
|
262.6
|
217.6
|
|||||
Lorillard
|
201.9
|
168.8
|
|||||
Boardwalk
Pipeline
|
39.1
|
35.7
|
|||||
Diamond
Offshore
|
107.2
|
72.3
|
|||||
Loews
Hotels
|
10.9
|
8.5
|
|||||
Corporate
and other
|
144.4
|
43.1
|
|||||
Income
from continuing operations
|
766.1
|
546.0
|
|||||
Discontinued
operations
|
2.2
|
(5.0
|
)
|
||||
Total
|
$
|
768.3
|
$
|
541.0
|
(a) |
Investment
gains (losses) included in Revenues, Pretax income (loss) and Net
income
(loss) are as follows:
|
Three
Months Ended March 31
|
2007
|
2006
|
|||||
Revenues
and pretax income (loss):
|
|||||||
CNA
Financial:
|
|||||||
Standard
Lines
|
$
|
(28.1
|
)
|
$
|
13.2
|
||
Specialty
Lines
|
(10.5
|
)
|
3.0
|
||||
Life
and Group Non-Core
|
0.6
|
(11.6
|
)
|
||||
Other
Insurance
|
16.6
|
4.2
|
|||||
Total
CNA Financial
|
(21.4
|
)
|
8.8
|
||||
Corporate
and other
|
135.4
|
(6.8
|
)
|
||||
Total
|
$
|
114.0
|
$
|
2.0
|
|||
Net
income (loss):
|
|||||||
CNA
Financial:
|
|||||||
Standard
Lines
|
$
|
(16.3
|
)
|
$
|
8.1
|
||
Specialty
Lines
|
(6.0
|
)
|
1.8
|
||||
Life
and Group Non-Core
|
0.3
|
(6.9
|
)
|
||||
Other
Insurance
|
9.6
|
(2.5
|
)
|
||||
Total
CNA Financial
|
(12.4
|
)
|
0.5
|
||||
Corporate
and other
|
87.4
|
(4.3
|
)
|
||||
Total
|
$
|
75.0
|
$
|
(3.8
|
)
|
Three
Months Ended March 31
|
2007
|
2006
|
|||||
(In
millions)
|
|||||||
Revenues:
|
|||||||
Net
investment income
|
$
|
5.6
|
$
|
3.9
|
|||
Investment
losses and other
|
(0.7
|
)
|
(0.1
|
)
|
|||
Total
revenues
|
4.9
|
3.8
|
|||||
Insurance
related expenses
|
(1.3
|
)
|
(9.7
|
)
|
|||
Income
(loss) before income taxes and minority interest
|
3.6
|
(5.9
|
)
|
||||
Income
tax (expense) benefit
|
(1.1
|
)
|
0.4
|
||||
Minority
interest
|
(0.3
|
)
|
0.5
|
||||
Net
income (loss) from discontinued operations
|
$
|
2.2
|
$
|
(5.0
|
)
|
March
31,
|
December
31,
|
||||||
2007
|
2006
|
||||||
(In
millions)
|
|||||||
Assets:
|
|||||||
Investments
|
$
|
319.6
|
$
|
317.1
|
|||
Reinsurance
receivables
|
34.9
|
32.8
|
|||||
Cash
|
23.2
|
40.1
|
|||||
Other
assets
|
7.3
|
2.8
|
|||||
Total
assets
|
385.0
|
392.8
|
|||||
Liabilities:
|
|||||||
Insurance
reserves
|
301.8
|
307.8
|
|||||
Other
liabilities
|
10.5
|
17.2
|
|||||
Total
liabilities
|
312.3
|
325.0
|
|||||
Net
assets of discontinued operations
|
$
|
72.7
|
$
|
67.8
|
March
31, 2007
|
CNA
Financial
|
Lorillard
|
Boardwalk
Pipeline
|
Diamond
Offshore
|
Loews
Hotels
|
Corporate
and
Other
|
Eliminations
|
Total
|
|||||||||||||||||
(In
millions)
|
|||||||||||||||||||||||||
Assets:
|
|||||||||||||||||||||||||
Investments
|
$
|
45,201.6
|
$
|
1,448.4
|
$
|
561.9
|
$
|
544.0
|
$
|
18.5
|
$
|
5,647.1
|
$
|
53,421.5
|
|||||||||||
Cash
|
90.6
|
0.8
|
1.4
|
9.8
|
17.0
|
8.9
|
128.5
|
||||||||||||||||||
Receivables
|
12,333.7
|
18.1
|
86.6
|
464.8
|
36.6
|
139.0
|
$
|
(14.8
|
)
|
13,064.0
|
|||||||||||||||
Property,
plant and equipment
|
262.3
|
200.0
|
2,191.2
|
2,674.3
|
367.1
|
25.5
|
5,720.4
|
||||||||||||||||||
Deferred
income taxes
|
834.4
|
519.3
|
0.3
|
14.9
|
(763.7
|
)
|
605.2
|
||||||||||||||||||
Goodwill
and other intangible assets
|
106.0
|
163.5
|
20.3
|
2.6
|
5.0
|
297.4
|
|||||||||||||||||||
Investments
in capital stocks of
|
|||||||||||||||||||||||||
subsidiaries
|
12,494.9
|
(12,494.9
|
)
|
||||||||||||||||||||||
Other
assets
|
1,029.0
|
326.7
|
219.8
|
84.7
|
45.1
|
93.6
|
(0.7
|
)
|
1,798.2
|
||||||||||||||||
Deferred
acquisition costs of
|
|||||||||||||||||||||||||
insurance
subsidiaries
|
1,189.5
|
1,189.5
|
|||||||||||||||||||||||
Separate
account business
|
514.9
|
514.9
|
|||||||||||||||||||||||
Total
assets
|
$
|
61,562.0
|
$
|
2,513.3
|
$
|
3,224.7
|
$
|
3,797.9
|
$
|
486.9
|
$
|
18,428.9
|
$
|
(13,274.1
|
)
|
$
|
76,739.6
|
||||||||
Liabilities
and Shareholders’ Equity:
|
|||||||||||||||||||||||||
Insurance
reserves
|
$
|
41,066.2
|
$
|
(0.7
|
)
|
$
|
41,065.5
|
||||||||||||||||||
Payable
for securities purchased
|
1,284.5
|
$
|
96.1
|
1,380.6
|
|||||||||||||||||||||
Collateral
on loaned securities
|
2,914.1
|
2,914.1
|
|||||||||||||||||||||||
Short-term
debt
|
$
|
4.3
|
4.3
|
||||||||||||||||||||||
Long-term
debt
|
2,156.0
|
$
|
1,351.2
|
$
|
524.4
|
231.0
|
865.5
|
5,128.1
|
|||||||||||||||||
Reinsurance
balances payable
|
576.8
|
576.8
|
|||||||||||||||||||||||
Deferred
income taxes
|
52.8
|
359.1
|
48.8
|
303.0
|
(763.7
|
)
|
|||||||||||||||||||
Other
liabilities
|
2,608.5
|
$
|
1,274.4
|
323.3
|
426.9
|
23.9
|
218.7
|
(43.4
|
)
|
4,832.3
|
|||||||||||||||
Separate
account business
|
514.9
|
514.9
|
|||||||||||||||||||||||
Total
liabilities
|
51,121.0
|
1,274.4
|
1,727.3
|
1,310.4
|
308.0
|
1,483.3
|
(807.8
|
)
|
56,416.6
|
||||||||||||||||
Minority
interest
|
1,418.9
|
780.9
|
1,205.7
|
3,405.5
|
|||||||||||||||||||||
Shareholders’
equity
|
9,022.1
|
1,238.9
|
716.5
|
1,281.8
|
178.9
|
16,945.6
|
(12,466.3
|
)
|
16,917.5
|
||||||||||||||||
Total
liabilities and shareholders’ equity
|
$
|
61,562.0
|
$
|
2,513.3
|
$
|
3,224.7
|
$
|
3,797.9
|
$
|
486.9
|
$
|
18,428.9
|
$
|
(13,274.1
|
)
|
$
|
76,739.6
|
December
31, 2006
|
CNA
Financial
|
Lorillard
|
Boardwalk
Pipeline
|
Diamond
Offshore
|
Loews
Hotels
|
Corporate
and
Other
|
Eliminations
|
Total
|
|||||||||||||||||
(In
millions)
|
|||||||||||||||||||||||||
Assets:
|
|||||||||||||||||||||||||
Investments
|
$
|
44,094.2
|
$
|
1,767.5
|
$
|
397.9
|
$
|
815.6
|
$
|
9.7
|
$
|
6,803.9
|
$
|
53,888.8
|
|||||||||||
Cash
|
83.9
|
1.2
|
1.1
|
10.2
|
14.8
|
22.6
|
133.8
|
||||||||||||||||||
Receivables
|
12,202.4
|
15.6
|
87.7
|
567.5
|
27.6
|
128.6
|
$
|
(2.1
|
)
|
13,027.3
|
|||||||||||||||
Property,
plant and equipment
|
240.9
|
196.4
|
2,024.4
|
2,653.8
|
362.5
|
23.3
|
5,501.3
|
||||||||||||||||||
Deferred
income taxes
|
884.6
|
495.7
|
14.8
|
(774.2
|
)
|
620.9
|
|||||||||||||||||||
Goodwill
and other intangible assets
|
106.0
|
163.5
|
21.8
|
2.6
|
5.0
|
298.9
|
|||||||||||||||||||
Investments
in capital stocks of
|
|||||||||||||||||||||||||
subsidiaries
|
12,313.4
|
(12,313.4
|
)
|
||||||||||||||||||||||
Other
assets
|
933.3
|
282.8
|
263.5
|
101.5
|
41.9
|
93.5
|
1,716.5
|
||||||||||||||||||
Deferred
acquisition costs of
|
|||||||||||||||||||||||||
insurance
subsidiaries
|
1,190.4
|
1,190.4
|
|||||||||||||||||||||||
Separate
account business
|
503.0
|
503.0
|
|||||||||||||||||||||||
Total
assets
|
$
|
60,238.7
|
$
|
2,759.2
|
$
|
2,938.1
|
$
|
4,170.4
|
$
|
459.1
|
$
|
19,405.1
|
$
|
(13,089.7
|
)
|
$
|
76,880.9
|
||||||||
Liabilities
and Shareholders’ Equity:
|
|||||||||||||||||||||||||
Insurance
reserves
|
$
|
41,079.9
|
$
|
41,079.9
|
|||||||||||||||||||||
Payable
for securities purchased
|
320.0
|
$
|
0.2
|
$
|
726.5
|
1,046.7
|
|||||||||||||||||||
Collateral
on loaned securities
|
2,850.9
|
750.6
|
3,601.5
|
||||||||||||||||||||||
Short-term
debt
|
0.3
|
4.3
|
4.6
|
||||||||||||||||||||||
Long-term
debt
|
2,155.5
|
$
|
1,350.9
|
$
|
964.3
|
231.7
|
865.4
|
5,567.8
|
|||||||||||||||||
Reinsurance
balances payable
|
539.1
|
539.1
|
|||||||||||||||||||||||
Deferred
income taxes
|
44.4
|
438.6
|
50.0
|
241.2
|
$
|
(774.2
|
)
|
||||||||||||||||||
Other
liabilities
|
2,734.1
|
$
|
1,463.9
|
345.4
|
400.8
|
4.3
|
206.7
|
(15.0
|
)
|
5,140.2
|
|||||||||||||||
Separate
account business
|
503.0
|
503.0
|
|||||||||||||||||||||||
Total
liabilities
|
50,182.8
|
1,463.9
|
1,740.7
|
1,803.7
|
290.5
|
2,790.4
|
(789.2
|
)
|
57,482.8
|
||||||||||||||||
Minority
interest
|
1,349.6
|
484.8
|
1,061.9
|
2,896.3
|
|||||||||||||||||||||
Shareholders’
equity
|
8,706.3
|
1,295.3
|
712.6
|
1,304.8
|
168.6
|
16,614.7
|
(12,300.5
|
)
|
16,501.8
|
||||||||||||||||
Total
liabilities and shareholders’ equity
|
$
|
60,238.7
|
$
|
2,759.2
|
$
|
2,938.1
|
$
|
4,170.4
|
$
|
459.1
|
$
|
19,405.1
|
$
|
(13,089.7
|
)
|
$
|
76,880.9
|
Three
Months Ended March 31, 2007
|
CNA
Financial
|
Lorillard
|
Boardwalk
Pipeline
|
Diamond
Offshore
|
Loews
Hotels
|
Corporate
and
Other
|
Eliminations
|
Total
|
|||||||||||||||||
(In
millions)
|
|||||||||||||||||||||||||
Revenues:
|
|||||||||||||||||||||||||
Insurance
premiums
|
$
|
1,862.7
|
$
|
(0.4
|
)
|
$
|
1,862.3
|
||||||||||||||||||
Net
investment income
|
608.2
|
$
|
31.5
|
$
|
4.6
|
$
|
9.8
|
$
|
0.4
|
$
|
110.9
|
765.4
|
|||||||||||||
Intercompany
interest and dividends
|
581.1
|
(581.1
|
)
|
||||||||||||||||||||||
Investment
gains (losses)
|
(21.4
|
)
|
0.1
|
(21.3
|
)
|
||||||||||||||||||||
Gain
on issuance of subsidiary stock
|
(3.0
|
)
|
138.3
|
135.3
|
|||||||||||||||||||||
Manufactured
products
|
913.0
|
46.2
|
959.2
|
||||||||||||||||||||||
Other
|
67.5
|
0.4
|
185.8
|
609.1
|
94.9
|
1.1
|
958.8
|
||||||||||||||||||
Total
|
2,517.0
|
945.0
|
190.4
|
615.9
|
95.3
|
877.6
|
(581.5
|
)
|
4,659.7
|
||||||||||||||||
Expenses:
|
|||||||||||||||||||||||||
Insurance
claims and policyholders’
|
|||||||||||||||||||||||||
benefits
|
1,447.9
|
1,447.9
|
|||||||||||||||||||||||
Amortization
of deferred acquisition costs
|
380.9
|
380.9
|
|||||||||||||||||||||||
Cost
of manufactured products sold
|
544.3
|
23.2
|
567.5
|
||||||||||||||||||||||
Other
operating expenses
|
215.8
|
81.8
|
93.3
|
299.3
|
74.6
|
33.1
|
(0.4
|
)
|
797.5
|
||||||||||||||||
Interest
|
34.4
|
16.8
|
10.5
|
2.9
|
14.0
|
78.6
|
|||||||||||||||||||
Total
|
2,079.0
|
626.1
|
110.1
|
309.8
|
77.5
|
70.3
|
(0.4
|
)
|
3,272.4
|
||||||||||||||||
438.0
|
318.9
|
80.3
|
306.1
|
17.8
|
807.3
|
(581.1
|
)
|
1,387.3
|
|||||||||||||||||
Income
tax expense
|
133.4
|
116.9
|
25.0
|
93.8
|
6.9
|
79.3
|
455.3
|
||||||||||||||||||
Minority
interest
|
42.0
|
16.2
|
107.7
|
165.9
|
|||||||||||||||||||||
Total
|
175.4
|
116.9
|
41.2
|
201.5
|
6.9
|
79.3
|
621.2
|
||||||||||||||||||
Income
from continuing operations
|
262.6
|
202.0
|
39.1
|
104.6
|
10.9
|
728.0
|
(581.1
|
)
|
766.1
|
||||||||||||||||
Discontinued
operations, net
|
2.2
|
2.2
|
|||||||||||||||||||||||
Net
income
|
$
|
264.8
|
$
|
202.0
|
$
|
39.1
|
$
|
104.6
|
$
|
10.9
|
$
|
728.0
|
$
|
(581.1
|
)
|
$
|
768.3
|
Three
Months Ended March 31, 2006
|
CNA
Financial
|
Lorillard
|
Boardwalk
Pipeline
|
Diamond
Offshore
|
Loews
Hotels
|
Corporate
and
Other
|
Eliminations
|
Total
|
|||||||||||||||||
(In
millions)
|
|||||||||||||||||||||||||
Revenues:
|
|||||||||||||||||||||||||
Insurance
premiums
|
$
|
1,868.6
|
$
|
1,868.6
|
|||||||||||||||||||||
Net
investment income
|
570.4
|
$
|
24.8
|
$
|
0.5
|
$
|
8.4
|
$
|
0.2
|
$
|
99.8
|
704.1
|
|||||||||||||
Intercompany
interest and dividends
|
336.5
|
$
|
(336.5
|
)
|
|||||||||||||||||||||
Investment
gains (losses)
|
8.8
|
(0.6
|
)
|
(0.2
|
)
|
(6.0
|
)
|
2.0
|
|||||||||||||||||
Manufactured
products
|
854.8
|
43.6
|
898.4
|
||||||||||||||||||||||
Other
|
52.7
|
174.5
|
450.3
|
93.2
|
0.7
|
771.4
|
|||||||||||||||||||
Total
|
2,500.5
|
879.0
|
175.0
|
458.5
|
93.4
|
474.6
|
(336.5
|
)
|
4,244.5
|
||||||||||||||||
Expenses:
|
|||||||||||||||||||||||||
Insurance
claims and policyholders’
|
|||||||||||||||||||||||||
benefits
|
1,492.0
|
1,492.0
|
|||||||||||||||||||||||
Amortization
of deferred acquisition costs
|
370.2
|
370.2
|
|||||||||||||||||||||||
Cost
of manufactured products sold
|
511.7
|
21.6
|
533.3
|
||||||||||||||||||||||
Other
operating expenses
|
253.0
|
92.8
|
90.0
|
246.6
|
76.6
|
30.8
|
789.8
|
||||||||||||||||||
Interest
|
30.2
|
15.6
|
6.8
|
2.9
|
19.1
|
74.6
|
|||||||||||||||||||
Total
|
2,145.4
|
604.5
|
105.6
|
253.4
|
79.5
|
71.5
|
3,259.9
|
||||||||||||||||||
355.1
|
274.5
|
69.4
|
205.1
|
13.9
|
403.1
|
(336.5
|
)
|
984.6
|
|||||||||||||||||
Income
tax expense (benefit)
|
109.5
|
106.1
|
23.6
|
66.5
|
5.4
|
23.1
|
334.2
|
||||||||||||||||||
Minority
interest
|
28.0
|
10.1
|
66.3
|
104.4
|
|||||||||||||||||||||
Total
|
137.5
|
106.1
|
33.7
|
132.8
|
5.4
|
23.1
|
438.6
|
||||||||||||||||||
Income
from continuing operations
|
217.6
|
168.4
|
35.7
|
72.3
|
8.5
|
380.0
|
(336.5
|
)
|
546.0
|
||||||||||||||||
Discontinued
operations, net
|
(5.0
|
)
|
(5.0
|
)
|
|||||||||||||||||||||
Net
income
|
$
|
212.6
|
$
|
168.4
|
$
|
35.7
|
$
|
72.3
|
$
|
8.5
|
$
|
380.0
|
$
|
(336.5
|
)
|
$
|
541.0
|
Page
|
|
No.
|
|
Overview
|
47
|
Consolidated
Financial Results
|
48
|
Classes
of Common Stock
|
48
|
Parent
Company Structure
|
49
|
Critical
Accounting Estimates
|
49
|
Results
of Operations by Business Segment
|
50
|
CNA
Financial
|
50
|
Standard
Lines
|
51
|
Specialty
Lines
|
52
|
Life
and Group Non-Core
|
53
|
Other
Insurance
|
54
|
APMT
Reserves
|
54
|
Lorillard
|
60
|
Results
of Operations
|
60
|
Business
Environment
|
62
|
Boardwalk
Pipeline
|
63
|
Diamond
Offshore
|
64
|
Loews
Hotels
|
66
|
Corporate
and Other
|
66
|
Liquidity
and Capital Resources
|
67
|
CNA
Financial
|
67
|
Lorillard
|
68
|
Boardwalk
Pipeline
|
70
|
Diamond
Offshore
|
70
|
Loews
Hotels
|
71
|
Corporate
and Other
|
72
|
Investments
|
72
|
Accounting
Standards
|
78
|
Forward-Looking
Statements
|
78
|
·
|
commercial
property and casualty insurance (CNA Financial Corporation (“CNA”), an 89%
owned subsidiary);
|
·
|
production
and sale of cigarettes (Lorillard, Inc. (“Lorillard”), a wholly owned
subsidiary);
|
·
|
operation
of interstate natural gas transmission
pipeline systems
(Boardwalk Pipeline Partners, LP
(“Boardwalk Pipeline”),
a 75% owned subsidiary);
|
·
|
operation
of offshore oil and gas drilling rigs (Diamond Offshore Drilling,
Inc.
(“Diamond Offshore”), a 51% owned
subsidiary);
|
·
|
operation
of hotels (Loews Hotels Holding Corporation (“Loews Hotels”), a wholly
owned subsidiary)
and
|
·
|
distribution
and sale of watches and clocks (Bulova Corporation (“Bulova”), a wholly
owned subsidiary).
|
Three
Months Ended March 31
|
2007
|
2006
|
|||||
(In
millions, except per share data)
|
|||||||
Net
income attributable to Loews common stock:
|
|||||||
Income
before net investment gains (losses)
|
$
|
573.5
|
$
|
482.0
|
|||
Net
investment gains (losses) (a)
|
75.0
|
(3.6
|
)
|
||||
Income
from continuing operations
|
648.5
|
478.4
|
|||||
Discontinued
operations, net
|
2.2
|
(5.0
|
)
|
||||
Net
income attributable to Loews common stock
|
650.7
|
473.4
|
|||||
Net
income attributable to Carolina Group stock
|
117.6
|
67.6
|
|||||
Consolidated
net income
|
$
|
768.3
|
$
|
541.0
|
|||
Net
income per share:
|
|||||||
Loews
common stock
|
|||||||
Income
from continuing operations
|
$
|
1.20
|
$
|
0.86
|
|||
Discontinued
operations, net
|
(0.01
|
)
|
|||||
Loews
common stock
|
$
|
1.20
|
$
|
0.85
|
|||
Carolina
Group stock
|
$
|
1.08
|
$
|
0.86
|
(a)
|
Includes
a gain of $89.2 million related to a reduction in the Company’s ownership
interest in Diamond Offshore from the conversion of Diamond Offshore’s
1.5% convertible debt into Diamond Offshore common
stock.
|
·
|
our
100% stock ownership interest in Lorillard,
Inc.;
|
·
|
notional,
intergroup debt owed by the Carolina Group to the Loews Group ($1.1
billion outstanding at March 31, 2007), bearing interest at the
annual
rate of 8.0% and, subject to optional prepayment, due December
31, 2021;
and
|
·
|
any
and all liabilities, costs and expenses arising out of or related
to
tobacco or tobacco-related
businesses.
|
·
|
Insurance
Reserves
|
·
|
Reinsurance
|
·
|
Tobacco
and Other Litigation
|
·
|
Valuation
of Investments and Impairment of
Securities
|
·
|
Long
Term Care Products
|
·
|
Pension
and Postretirement Benefit
Obligations
|
Three
Months Ended March 31
|
2007
|
2006
|
|||||
(In
millions, except %)
|
|||||||
Net
written premiums
|
$
|
1,081.0
|
$
|
1,110.0
|
|||
Net
earned premiums
|
1,060.0
|
1,086.0
|
|||||
Net
investment income
|
258.5
|
228.3
|
|||||
Net
operating income
|
158.4
|
121.7
|
|||||
Net
realized investment gains (losses)
|
(16.3
|
)
|
8.1
|
||||
Net
income
|
142.1
|
129.8
|
|||||
Ratios:
|
|||||||
Loss
and loss adjustment expense
|
69.6
|
%
|
71.8
|
%
|
|||
Expense
|
29.1
|
31.2
|
|||||
Dividend
|
0.4
|
0.4
|
|||||
Combined
|
99.1
|
%
|
103.4
|
%
|
March
31,
|
December
31,
|
||||||
2007
|
2006
|
||||||
(In
millions)
|
|||||||
Gross
Case Reserves
|
$
|
6,729.0
|
$
|
6,746.0
|
|||
Gross
IBNR Reserves
|
8,207.0
|
8,188.0
|
|||||
Total
Gross Carried Claim and Claim Adjustment Expense Reserves
|
$
|
14,936.0
|
$
|
14,934.0
|
|||
Net
Case Reserves
|
$
|
5,199.0
|
$
|
5,234.0
|
|||
Net
IBNR Reserves
|
6,642.0
|
6,632.0
|
|||||
Total
Net Carried Claim and Claim Adjustment Expense Reserves
|
$
|
11,841.0
|
$
|
11,866.0
|
Three
Months Ended March 31
|
2007
|
2006
|
|||||
(In
millions, except %)
|
|||||||
Net
written premiums
|
$
|
650.0
|
$
|
648.0
|
|||
Net
earned premiums
|
648.0
|
628.0
|
|||||
Net
investment income
|
110.0
|
87.0
|
|||||
Net
operating income
|
105.3
|
103.7
|
|||||
Net
realized investment gains (losses)
|
(6.0
|
)
|
1.8
|
||||
Net
income
|
99.3
|
105.5
|
|||||
Ratios:
|
|||||||
Loss
and loss adjustment expense
|
61.5
|
%
|
59.3
|
%
|
|||
Expense
|
26.8
|
26.1
|
|||||
Dividend
|
0.2
|
0.2
|
|||||
Combined
|
88.5
|
%
|
85.6
|
%
|
March
31,
|
December
31,
|
||||||
2007
|
2006
|
||||||
(In
millions)
|
|||||||
Gross
Case Reserves
|
$
|
1,689.0
|
$
|
1,715.0
|
|||
Gross
IBNR Reserves
|
4,025.0
|
3,814.0
|
|||||
Total
Gross Carried Claim and Claim Adjustment Expense Reserves
|
$
|
5,714.0
|
$
|
5,529.0
|
|||
Net
Case Reserves
|
$
|
1,352.0
|
$
|
1,350.0
|
|||
Net
IBNR Reserves
|
3,034.0
|
2,921.0
|
|||||
Total
Net Carried Claim and Claim Adjustment Expense Reserves
|
$
|
4,386.0
|
$
|
4,271.0
|
Three
Months Ended March 31
|
2007
|
2006
|
|||||
(In
millions)
|
|||||||
Net
earned premiums
|
$
|
156.0
|
$
|
163.0
|
|||
Net
investment income
|
161.0
|
187.1
|
|||||
Net
operating income (loss)
|
2.3
|
(2.6
|
)
|
||||
Net
realized investment gains (losses)
|
0.3
|
(6.9
|
)
|
||||
Net
income (loss)
|
2.6
|
(9.5
|
)
|
Three
Months Ended March 31
|
2007
|
2006
|
|||||
(In
millions)
|
|||||||
Net
investment income
|
$
|
78.0
|
$
|
68.0
|
|||
Revenues
|
84.1
|
51.6
|
|||||
Net
operating income (loss)
|
9.0
|
(5.7
|
)
|
||||
Net
realized investment gains (losses)
|
9.6
|
(2.5
|
)
|
||||
Net
income (loss)
|
18.6
|
(8.2
|
)
|
March
31,
|
December
31,
|
||||||
2007
|
2006
|
||||||
(In
millions)
|
|||||||
Gross
Case Reserves
|
$
|
2,484.0
|
$
|
2,511.0
|
|||
Gross
IBNR Reserves
|
3,291.0
|
3,528.0
|
|||||
Total
Gross Carried Claim and Claim Adjustment Expense Reserves
|
5,775.0
|
$
|
6,039.0
|
||||
Net
Case Reserves
|
$
|
1,469.0
|
$
|
1,453.0
|
|||
Net
IBNR Reserves
|
1,864.0
|
1,999.0
|
|||||
Total
Net Carried Claim and Claim Adjustment Expense Reserves
|
$
|
3,333.0
|
$
|
3,452.0
|
March
31, 2007
|
Number
of
Policyholders
|
Net
Paid
Losses
|
Net
Asbestos
Reserves
|
Percent
of
Asbestos
Net
Reserves
|
|||||||||
(In
millions of dollars)
|
|||||||||||||
Policyholders
with settlement agreements
|
|||||||||||||
Structured
settlements
|
16
|
$
|
15.0
|
$
|
172.0
|
12.4
|
%
|
||||||
Wellington
|
3
|
14.0
|
1.0
|
||||||||||
Coverage
in place
|
37
|
36.0
|
79.0
|
5.7
|
|||||||||
Total
with settlement agreements
|
56
|
51.0
|
265.0
|
19.1
|
|||||||||
Other
policyholders with active accounts
|
|||||||||||||
Large
asbestos accounts
|
223
|
7.0
|
257.0
|
18.5
|
|||||||||
Small
asbestos accounts
|
1,062
|
3.0
|
93.0
|
6.7
|
|||||||||
Total
other policyholders
|
1,285
|
10.0
|
350.0
|
25.2
|
|||||||||
Assumed
reinsurance and pools
|
3.0
|
139.0
|
10.0
|
||||||||||
Unassigned
IBNR
|
634.0
|
45.7
|
|||||||||||
Total
|
1,341
|
$
|
64.0
|
$
|
1,388.0
|
100.0
|
%
|
December
31, 2006
|
Number
of
Policyholders
|
Net
Paid
(Recovered)
Losses
|
Net
Asbestos
Reserves
|
Percent
of
Asbestos
Net
Reserves
|
|||||||||
(In
millions of dollars)
|
|||||||||||||
Policyholders
with settlement agreements
|
|||||||||||||
Structured
settlements
|
15
|
$
|
22.0
|
$
|
171.0
|
11.8
|
%
|
||||||
Wellington
|
3
|
(1.0
|
)
|
14.0
|
1.0
|
||||||||
Coverage
in place
|
38
|
(18.0
|
)
|
132.0
|
9.0
|
||||||||
Total
with settlement agreements
|
56
|
3.0
|
317.0
|
21.8
|
|||||||||
Other
policyholders with active accounts
|
|||||||||||||
Large
asbestos accounts
|
220
|
76.0
|
254.0
|
17.5
|
|||||||||
Small
asbestos accounts
|
1,080
|
17.0
|
101.0
|
7.0
|
|||||||||
Total
other policyholders
|
1,300
|
93.0
|
355.0
|
24.5
|
|||||||||
Assumed
reinsurance and pools
|
6.0
|
141.0
|
9.7
|
||||||||||
Unassigned
IBNR
|
639.0
|
44.0
|
|||||||||||
Total
|
1,356
|
$
|
102.0
|
$
|
1,452.0
|
100.0
|
%
|
March
31, 2007
|
Number
of
Policyholders
|
Net
Paid
Losses
|
Net
Environmental
Pollution
Reserves
|
Percent
of
Environmental
Pollution
Net
Reserve
|
|||||||||
(In
millions of dollars)
|
|||||||||||||
Policyholders
with Settlement Agreements
|
|||||||||||||
Structured
settlements
|
9
|
$
|
4.0
|
$
|
6.0
|
2.2
|
%
|
||||||
Coverage
in place
|
18
|
1.0
|
14.0
|
5.0
|
|||||||||
Total
with Settlement Agreements
|
27
|
5.0
|
20.0
|
7.2
|
|||||||||
Other
Policyholders with Active Accounts
|
|||||||||||||
Large
pollution accounts
|
111
|
2.0
|
52.0
|
18.8
|
|||||||||
Small
pollution accounts
|
325
|
1.0
|
46.0
|
16.6
|
|||||||||
Total
Other Policyholders
|
436
|
3.0
|
98.0
|
35.4
|
|||||||||
Assumed
Reinsurance & Pools
|
32.0
|
11.6
|
|||||||||||
Unassigned
IBNR
|
127.0
|
45.8
|
|||||||||||
Total
|
463
|
$
|
8.0
|
$
|
277.0
|
100.0
|
%
|
December
31, 2006
|
|||||||||||||
Policyholders
with Settlement Agreements
|
|||||||||||||
Structured
settlements
|
11
|
$
|
16.0
|
$
|
9.0
|
3.2
|
%
|
||||||
Coverage
in place
|
18
|
5.0
|
14.0
|
4.9
|
|||||||||
Total
with Settlement Agreements
|
29
|
21.0
|
23.0
|
8.1
|
|||||||||
Other
Policyholders with Active Accounts
|
|||||||||||||
Large
pollution accounts
|
115
|
20.0
|
58.0
|
20.4
|
|||||||||
Small
pollution accounts
|
346
|
9.0
|
46.0
|
16.1
|
|||||||||
Total
Other Policyholders
|
461
|
29.0
|
104.0
|
36.5
|
|||||||||
Assumed
Reinsurance & Pools
|
1.0
|
32.0
|
11.2
|
||||||||||
Unassigned
IBNR
|
126.0
|
44.2
|
|||||||||||
Total
|
490
|
$
|
51.0
|
$
|
285.0
|
100.0
|
%
|
Three
Months Ended March 31
|
2007
|
2006
|
|||||
(In
millions)
|
|||||||
Revenues:
|
|||||||
Manufactured
products
|
$
|
913.0
|
$
|
854.8
|
|||
Net
investment income
|
31.5
|
24.8
|
|||||
Investment
gains (losses)
|
0.1
|
(0.6
|
)
|
||||
Other
|
0.4
|
||||||
Total
|
945.0
|
879.0
|
|||||
Expenses:
|
|||||||
Cost
of sales
|
544.3
|
511.7
|
|||||
Other
operating
|
81.8
|
92.8
|
|||||
Total
|
626.1
|
604.5
|
|||||
318.9
|
274.5
|
||||||
Income
tax expense
|
116.9
|
106.1
|
|||||
Net
income
|
$
|
202.0
|
$
|
168.4
|
·
|
the
number and types of cases filed and
appealed;
|
·
|
the
number of cases tried and appealed;
|
·
|
the
development of the law;
|
·
|
the
application of new or different theories of liability by plaintiffs
and
their counsel; and
|
·
|
litigation
strategy and tactics.
|
Three
Months Ended March 31
|
2007
|
2006
|
|||||
(Units
in billions)
|
|||||||
Total
domestic Lorillard unit volume (1)
|
8.387
|
8.468
|
|||||
Total
domestic industry unit volume (1)
|
84.265
|
87.990
|
|||||
Lorillard’s
share of the domestic market (1)
|
10.0
|
%
|
9.6
|
%
|
|||
Lorillard’s
premium segment as a percentage of its
|
|||||||
total
domestic volume (1)
|
94.9
|
%
|
95.1
|
%
|
|||
Lorillard’s
share of the premium segment (1)
|
13.1
|
%
|
12.7
|
%
|
|||
Newport
share of the domestic market (1)
|
9.2
|
%
|
8.8
|
%
|
|||
Newport
share of the premium segment (1)
|
12.7
|
%
|
12.2
|
%
|
|||
Total
menthol segment market share for the industry (2)
|
28.5
|
%
|
28.1
|
%
|
|||
Total
discount segment market share for the industry (1)
|
27.9
|
%
|
27.7
|
%
|
|||
Newport’s
share of the menthol segment (2)
|
33.6
|
%
|
33.0
|
%
|
|||
Newport
as a percentage of Lorillard’s (3):
|
|||||||
Total
volume
|
92.4
|
%
|
92.0
|
%
|
|||
Net
sales
|
94.0
|
%
|
93.3
|
%
|
(1)
|
Management
Science Associates, Inc.
|
(2)
|
Lorillard
proprietary data
|
(3)
|
Lorillard
shipment reports
|
·
|
A
substantial volume
of
litigation seeking compensatory and punitive damages ranging
into the billions
of dollars,
as well as equitable and
injunctive relief, arising out of allegations
of
cancer and other health
effects resulting
from the use
of
cigarettes,
addiction
to smoking
or
exposure to environmental
tobacco smoke,
including
claims for economic damages relating to alleged misrepresentation
concerning the use of descriptors such as “lights,” as well as other
alleged damages. Please read Item 3 - Legal Proceedings of our
2006 Annual
Report on Form 10-K and Note 10 of the Notes to Consolidated Condensed
Financial Statements included in Item 1 of this Report for information
with respect to litigation and the State Settlement
Agreements.
|
·
|
Substantial
annual payments by Lorillard, continuing in perpetuity, and significant
restrictions on marketing and advertising agreed to under the terms
of the
State Settlement Agreements. The State Settlement Agreements impose
a
stream of future payment obligations on Lorillard and the other
major U.S.
cigarette manufacturers and place significant restrictions on their
ability to market and sell
cigarettes.
|
·
|
The
continuing contraction of the U.S. cigarette market, in which Lorillard
currently conducts its only significant business. As a result of
price
increases, restrictions on advertising and promotions, increases
in
regulation and excise taxes, health concerns, a decline in the
social
acceptability of smoking, increased pressure
|
·
|
Substantial
federal, state and local excise taxes which are reflected in the
retail
price of cigarettes. In the first three months of 2007, the federal
excise
tax was $0.39 per pack and combined state and local excise taxes
ranged
from $0.07 to $3.66 per pack. In the first three months of 2007,
excise
tax increases of $1.00 per pack were implemented in three states.
Proposals continue to be made to increase federal, state and local
excise
taxes. Lorillard believes that increases in excise and similar
taxes have
had an adverse impact on sales of cigarettes and that future increases,
the extent of which cannot be predicted, could result in further
volume
declines for the cigarette industry, including Lorillard, and an
increased
sales shift toward lower priced discount cigarettes rather than
premium
brands. In addition, Lorillard, other cigarette manufacturers and
importers are required to pay an assessment under a federal law
designed
to fund payments to tobacco quota holders and
growers.
|
·
|
Substantial
and increasing regulation of the tobacco industry and governmental
restrictions on smoking. Bills have been introduced in the U.S.
Congress
to grant the Food and Drug Administration (“FDA”) authority to regulate
tobacco products. Lorillard believes that FDA regulations, if enacted,
could among other things result in new restrictions on the manner
in which
cigarettes can be advertised and marketed, and may alter the way
cigarette
products are developed and manufactured. Lorillard also believes
that any
such proposals, if enacted, would provide Philip Morris, as the
largest
tobacco company in the country, with a competitive
advantage.
|
Three
Months Ended March 31
|
2007
|
2006
|
|||||
(In
millions)
|
|||||||
Revenues:
|
|||||||
Operating
|
$
|
185.8
|
$
|
174.5
|
|||
Net
investment income
|
4.6
|
0.5
|
|||||
Total
|
190.4
|
175.0
|
|||||
Expenses:
|
|||||||
Operating
|
93.3
|
90.0
|
|||||
Interest
|
16.8
|
15.6
|
|||||
Total
|
110.1
|
105.6
|
|||||
80.3
|
69.4
|
||||||
Income
tax expense
|
25.0
|
23.6
|
|||||
Minority
interest
|
16.2
|
10.1
|
|||||
Net
income
|
$
|
39.1
|
$
|
35.7
|
Three
Months Ended March 31
|
2007
|
2006
|
|||||
(In
millions)
|
|||||||
Revenues:
|
|||||||
Operating
|
$
|
609.1
|
$
|
450.3
|
|||
Net
investment income
|
9.8
|
8.4
|
|||||
Investment
gains (losses)
|
(3.0
|
)
|
(0.2
|
)
|
|||
Total
|
615.9
|
458.5
|
|||||
Expenses:
|
|||||||
Operating
|
299.3
|
246.6
|
|||||
Interest
|
10.5
|
6.8
|
|||||
Total
|
309.8
|
253.4
|
|||||
306.1
|
205.1
|
||||||
Income
tax expense
|
93.8
|
66.5
|
|||||
Minority
interest
|
107.7
|
66.3
|
|||||
Net
income
|
$
|
104.6
|
$
|
72.3
|
Three
Months Ended March 31
|
2007
|
2006
|
|||||
(In
millions)
|
|||||||
Revenues:
|
|||||||
Operating
|
$
|
94.9
|
$
|
93.2
|
|||
Net
investment income
|
0.4
|
0.2
|
|||||
Total
|
95.3
|
93.4
|
|||||
Expenses:
|
|||||||
Operating
|
74.6
|
76.6
|
|||||
Interest
|
2.9
|
2.9
|
|||||
Total
|
77.5
|
79.5
|
|||||
17.8
|
13.9
|
||||||
Income
tax expense
|
6.9
|
5.4
|
|||||
Net
income
|
$
|
10.9
|
$
|
8.5
|
Three
Months Ended March 31
|
2007
|
2006
|
|||||
(In
millions)
|
|||||||
Revenues:
|
|||||||
Manufactured
products
|
$
|
46.2
|
$
|
43.6
|
|||
Net
investment income
|
110.9
|
99.8
|
|||||
Investment
gains (losses)
|
138.3
|
(6.0
|
)
|
||||
Other
|
0.7
|
0.7
|
|||||
Total
|
296.1
|
138.1
|
|||||
Expenses:
|
|||||||
Cost
of sales
|
23.2
|
21.6
|
|||||
Operating
|
32.7
|
30.8
|
|||||
Interest
|
14.0
|
19.1
|
|||||
Total
|
69.9
|
71.5
|
|||||
226.2
|
66.6
|
||||||
Income
tax expense (benefit)
|
79.3
|
23.1
|
|||||
Net
income (loss)
|
$
|
146.9
|
$
|
43.5
|
·
|
inflation;
|
·
|
aggregate
volume of domestic cigarette
shipments;
|
·
|
market
share; and
|
·
|
industry
operating income.
|
Three
Months Ended March 31
|
2007
|
2006
|
|||||
(In
millions)
|
|||||||
Fixed
maturity securities
|
$
|
496.4
|
$
|
415.2
|
|||
Short-term
investments
|
49.5
|
65.1
|
|||||
Limited
partnerships
|
52.1
|
73.5
|
|||||
Equity
securities
|
5.1
|
6.1
|
|||||
Income
from trading portfolio (a)
|
2.8
|
42.3
|
|||||
Interest
on funds withheld and other deposits
|
(0.5
|
)
|
(24.8
|
)
|
|||
Other
|
10.7
|
3.0
|
|||||
Total
investment income
|
616.1
|
580.4
|
|||||
Investment
expense
|
(7.9
|
)
|
(10.0
|
)
|
|||
Net
investment income
|
$
|
608.2
|
$
|
570.4
|
(a)
|
The
change in net unrealized gains on trading securities, included
in net
investment income, was $2.0 million for the three months ended
March 31,
2007 and 2006.
|
Three
Months Ended March 31
|
2007
|
2006
|
|||||
(In
millions)
|
|||||||
Fixed
maturity securities:
|
|||||||
U.S.
Government bonds
|
$
|
1.7
|
$
|
3.8
|
|||
Corporate
and other taxable bonds
|
25.0
|
(19.7
|
)
|
||||
Tax-exempt
bonds
|
(11.5
|
)
|
25.4
|
||||
Asset-backed
bonds
|
(32.7
|
)
|
(9.4
|
)
|
|||
Redeemable
preferred stock
|
0.1
|
(0.2
|
)
|
||||
Total
fixed maturity securities
|
(17.4
|
)
|
(0.1
|
)
|
|||
Equity
securities
|
3.5
|
3.0
|
|||||
Derivative
securities
|
(7.7
|
)
|
6.9
|
||||
Short-term
investments
|
(0.2
|
)
|
(1.7
|
)
|
|||
Other
invested assets, including dispositions
|
0.3
|
||||||
Allocated
to participating policyholders’ and
|
|||||||
minority
interests
|
0.1
|
0.7
|
|||||
Total
realized investment gains (losses)
|
(21.4
|
)
|
8.8
|
||||
Income
tax (expense) benefit
|
7.4
|
(8.3
|
)
|
||||
Minority
interest
|
1.6
|
||||||
Net
realized investment gains (losses)
|
$
|
(12.4
|
)
|
$
|
0.5
|
Three
Months Ended March 31
|
2007
|
2006
|
|||||
(In
millions)
|
|||||||
Net
realized gains (losses) on fixed maturity
|
|||||||
and
equity securities:
|
|||||||
Fixed
maturity securities:
|
|||||||
Gross
realized gains
|
$
|
98.0
|
$
|
77.0
|
|||
Gross
realized losses
|
(115.0
|
)
|
(77.0
|
)
|
|||
Net
realized losses on fixed maturity securities
|
(17.0
|
)
|
|||||
Equity
securities:
|
|||||||
Gross
realized gains
|
7.0
|
4.0
|
|||||
Gross
realized losses
|
(4.0
|
)
|
(1.0
|
)
|
|||
Net
realized gains on equity securities
|
3.0
|
3.0
|
|||||
Net
realized gains (losses) on fixed maturity
|
|||||||
and
equity securities
|
$
|
(14.0
|
)
|
$
|
3.0
|
Issuer
Description and Discussion
|
Fair
Value
Date
of
Sale
|
Loss
On
Sale
|
Months
in
Unrealized
Loss
Prior
To
Sale (a)
|
|||||||
(In
millions)
|
||||||||||
Various
notes and bonds issued by the United States Treasury.
|
||||||||||
Securities
sold due to inflationary outlook and asset class
|
||||||||||
reallocation.
|
$
|
3,590.0
|
$
|
18.0
|
0-6
|
|||||
Total
|
$
|
3,590.0
|
$
|
18.0
|
(a)
|
Represents
the range of consecutive months the various positions were in an
unrealized loss prior to sale. 0-12+ means certain positions were
less
than 12 months, while others were greater than 12
months.
|
March
31, 2007
|
December
31, 2006
|
||||||||||||
(In
millions of dollars)
|
|||||||||||||
General
account investments:
|
|||||||||||||
Fixed
maturity securities available-for-sale:
|
|||||||||||||
U.S.
Treasury securities and obligations of
|
|||||||||||||
government
agencies
|
$
|
4,635.0
|
10.3
|
%
|
$
|
5,138.0
|
11.6
|
%
|
|||||
Asset-backed
securities
|
12,484.0
|
27.6
|
13,677.0
|
31.0
|
|||||||||
States,
municipalities and political subdivisions-
|
|||||||||||||
tax-exempt
|
5,665.0
|
12.5
|
5,146.0
|
11.7
|
|||||||||
Corporate
securities
|
7,003.0
|
15.5
|
7,132.0
|
16.2
|
|||||||||
Other
debt securities
|
3,699.0
|
8.2
|
3,642.0
|
8.2
|
|||||||||
Redeemable
preferred stock
|
1,033.0
|
2.3
|
912.0
|
2.1
|
|||||||||
Total
fixed maturity securities available-for-sale
|
34,519.0
|
76.4
|
35,647.0
|
80.8
|
|||||||||
Fixed
maturity securities trading:
|
|||||||||||||
U.S.
Treasury securities and obligations of
|
|||||||||||||
government
agencies
|
3.0
|
2.0
|
|||||||||||
Asset-backed
securities
|
57.0
|
0.1
|
55.0
|
0.1
|
|||||||||
Corporate
securities
|
120.0
|
0.3
|
133.0
|
0.3
|
|||||||||
Other
debt securities
|
19.0
|
14.0
|
|||||||||||
Redeemable
preferred stock
|
1.0
|
||||||||||||
Total
fixed maturity securities trading
|
200.0
|
0.4
|
204.0
|
0.4
|
|||||||||
Equity
securities available-for-sale:
|
|||||||||||||
Common
stock
|
461.0
|
1.0
|
452.0
|
1.0
|
|||||||||
Preferred
stock
|
146.0
|
0.3
|
145.0
|
0.4
|
|||||||||
Total
equity securities available-for-sale
|
607.0
|
1.3
|
597.0
|
1.4
|
|||||||||
Equity
securities trading
|
66.0
|
0.1
|
60.0
|
0.1
|
|||||||||
Short-term
investments available-for-sale
|
7,671.0
|
17.0
|
5,538.0
|
12.6
|
|||||||||
Short-term
investments trading
|
175.0
|
0.4
|
172.0
|
0.4
|
|||||||||
Limited
partnerships
|
1,940.0
|
4.3
|
1,852.0
|
4.2
|
|||||||||
Other
investments
|
25.0
|
0.1
|
26.0
|
0.1
|
|||||||||
Total
general account investments
|
$
|
45,203.0
|
100.0
|
%
|
$
|
44,096.0
|
100.0
|
%
|
Percent
of
Market
Value
|
Percent
of
Unrealized
Loss
|
||||||
Due
in one year or less
|
12.0
|
%
|
4.0
|
%
|
|||
Due
after one year through five years
|
43.0
|
41.0
|
|||||
Due
after five years through ten years
|
24.0
|
28.0
|
|||||
Due
after ten years
|
21.0
|
27.0
|
|||||
Total
|
100.0
|
%
|
100.0
|
%
|
Estimated
|
Fair
Value as a Percentage of Amortized Cost
|
Unrealized
|
|||||||||||||||||
March
31, 2007
|
Fair
Value
|
90-99%
|
80-89%
|
70-79%
|
<70%
|
Loss
|
|||||||||||||
(In
millions)
|
|||||||||||||||||||
Fixed
maturity securities:
|
|||||||||||||||||||
Non-investment
grade:
|
|||||||||||||||||||
0-6
months
|
$
|
143.0
|
$
|
1.0
|
$
|
1.0
|
|||||||||||||
7-12
months
|
30.0
|
1.0
|
1.0
|
||||||||||||||||
13-24
months
|
7.0
|
||||||||||||||||||
Greater
than 24 months
|
2.0
|
||||||||||||||||||
Total
non-investment grade
|
$
|
182.0
|
$
|
2.0
|
$
|
-
|
$
|
-
|
$
|
-
|
$
|
2.0
|
|||||||
December
31, 2006
|
|||||||||||||||||||
Fixed
maturity securities:
|
|||||||||||||||||||
Non-
investment grade:
|
|||||||||||||||||||
0-6
months
|
$
|
509.0
|
$
|
2.0
|
$
|
2.0
|
|||||||||||||
7-12
months
|
87.0
|
1.0
|
$
|
1.0
|
2.0
|
||||||||||||||
13-24
months
|
24.0
|
||||||||||||||||||
Greater
than 24 months
|
2.0
|
||||||||||||||||||
Total
non-investment grade
|
$
|
622.0
|
$
|
3.0
|
$
|
1.0
|
$
|
-
|
$
|
-
|
$
|
4.0
|
March
31, 2007
|
December
31, 2006
|
||||||||||||
(In
millions of dollars)
|
|||||||||||||
U.S.
Government and affiliated agency securities
|
$
|
4,765.0
|
14.1
|
%
|
$
|
5,285.0
|
15.1
|
%
|
|||||
Other
AAA rated
|
15,386.0
|
45.7
|
16,311.0
|
46.7
|
|||||||||
AA
and A rated
|
5,364.0
|
15.9
|
5,222.0
|
15.0
|
|||||||||
BBB
rated
|
4,866.0
|
14.4
|
4,933.0
|
14.1
|
|||||||||
Non
investment-grade
|
3,304.0
|
9.9
|
3,188.0
|
9.1
|
|||||||||
Total
|
$
|
33,685.0
|
100.0
|
%
|
$
|
34,939.0
|
100.0
|
%
|
March
31,
|
December
31,
|
||||||
2007
|
2006
|
||||||
(In
millions)
|
|||||||
Short-term
investments available-for-sale:
|
|||||||
Commercial
paper
|
$
|
2,532.0
|
$
|
923.0
|
|||
U.S.
Treasury securities
|
1,056.0
|
1,093.0
|
|||||
Money
market funds
|
413.0
|
196.0
|
|||||
Other,
including collateral held related to securities lending
|
3,670.0
|
3,326.0
|
|||||
Total
short-term investments available-for-sale
|
7,671.0
|
5,538.0
|
|||||
Short-term
investments trading:
|
|||||||
Commercial
paper
|
41.0
|
43.0
|
|||||
U.S.
Treasury securities
|
1.0
|
2.0
|
|||||
Money
market funds
|
133.0
|
127.0
|
|||||
Total
short-term investments trading
|
175.0
|
172.0
|
|||||
Total
short-term investments
|
$
|
7,846.0
|
$
|
5,710.0
|
·
|
the
impact of competitive products, policies and pricing and the competitive
environment in which CNA operates, including changes in CNA’s book of
business;
|
·
|
product
and policy availability and demand and market responses, including
the
level of CNA’s ability to obtain rate increases and decline or non-renew
under priced accounts, to achieve premium targets and profitability
and to
realize growth and retention
estimates;
|
·
|
development
of claims and the impact on loss reserves, including changes in
claim
settlement policies;
|
·
|
the
performance of reinsurance companies under reinsurance contracts
with
CNA;
|
·
|
the
effects upon insurance markets and upon industry business practices
and
relationships of current litigation, investigations and regulatory
activity by the New York State Attorney General’s office and other
authorities concerning contingent commission arrangements with
brokers and
bid solicitation activities;
|
·
|
legal
and regulatory activities with respect to certain non-traditional
and
finite-risk insurance products, and possible resulting changes
in
accounting and financial reporting in relation to such products,
including
our restatement of financial results in May of 2005 and CNA’s relationship
with an affiliate, Accord Re Ltd., as disclosed in connection with
that
restatement;
|
·
|
regulatory
limitations, impositions and restrictions upon CNA, including the
effects
of assessments and other surcharges for guaranty funds and second-injury
funds and other mandatory pooling
arrangements;
|
·
|
weather
and other natural physical events, including the severity and frequency
of
storms, hail, snowfall and other winter conditions, as well as
of natural
disasters such as hurricanes and earthquakes, as well as climate
change,
including effects on weather patterns, greenhouse gases, sea, land
and air
temperatures, sea levels, rain and
snow;
|
·
|
man-made
disasters, including the possible occurrence of terrorist attacks
and the
effect of the absence or insufficiency of applicable terrorism
legislation
on coverages;
|
·
|
the
unpredictability of the nature, targets, severity or frequency
of
potential terrorist events, as well as the uncertainty as to CNA’s ability
to contain its terrorism exposure effectively, notwithstanding
the
extension until 2007 of the Terrorism Risk Insurance Act of
2002;
|
·
|
the
occurrence of epidemics;
|
·
|
exposure
to liabilities due to claims made by insureds and others relating
to
asbestos remediation and health-based asbestos impairments, as
well as
exposure to liabilities for environmental pollution, mass tort
and
construction defect claims and exposure to liabilities due to claims
made
by insureds and others relating to lead-based
paint;
|
·
|
whether
a national privately financed trust to replace litigation of asbestos
claims with payments to claimants from the trust will be established
or
approved through federal legislation, or, if established and approved,
whether it will contain funding requirements in excess of CNA’s
established loss reserves or carried loss
reserves;
|
·
|
the
sufficiency of CNA’s loss reserves and the possibility of future increases
in reserves;
|
·
|
regulatory
limitations and restrictions, including limitations upon CNA’s ability to
receive dividends from its insurance subsidiaries imposed by state
regulatory agencies and minimum risk-based capital standards established
by the National Association of Insurance
Commissioners;
|
·
|
the
risks and uncertainties associated with CNA’s loss reserves as outlined
under “Critical
Accounting Estimates, Reserves - Estimates and Uncertainties”
in the MD&A portion of this
Report;
|
·
|
the
level of success in integrating acquired businesses and operations,
and in
consolidating, or selling existing
ones;
|
·
|
the
possibility of further changes in CNA’s ratings by ratings agencies,
including the inability to access certain markets or distribution
channels, and the required collateralization of future payment
obligations
as a result of such changes, and changes in rating agency policies
and
practices;
|
·
|
the
effects of corporate bankruptcies and accounting errors, such as
Enron and
WorldCom, on capital markets and on the markets for directors and
officers
and errors and omissions coverages;
|
·
|
general
economic and business conditions, including inflationary pressures
on
medical care costs, construction costs and other economic sectors
that
increase the severity of claims;
|
·
|
the
effectiveness of current initiatives by claims management to reduce
the
loss and expense ratios through more efficacious claims handling
techniques; and
|
·
|
changes
in the composition of CNA’s operating
segments.
|
·
|
health
concerns, claims and regulations relating to the use of tobacco
products
and exposure to environmental tobacco
smoke;
|
·
|
legislation,
including actual and potential excise tax increases, and the effects
of
tobacco litigation settlements on pricing and consumption
rates;
|
·
|
continued
intense competition from other cigarette manufacturers, including
significant levels of promotional activities and the presence of
a sizable
deep-discount category;
|
·
|
the
continuing decline in volume in the domestic cigarette
industry;
|
·
|
increasing
marketing and regulatory restrictions, governmental regulation
and
privately imposed smoking
restrictions;
|
·
|
litigation,
including risks associated with adverse jury and judicial determinations,
courts reaching conclusions at variance with the general understandings
of
applicable law, bonding requirements and the absence of adequate
appellate
remedies to get timely relief from any of the foregoing;
and
|
·
|
the
impact of each of the factors described under “Results of
Operations—Lorillard” in the MD&A portion of this
Report.
|
·
|
the
impact of changes in demand for oil and natural gas and oil and
gas price
fluctuations on exploration and production
activity;
|
·
|
costs
and timing of rig upgrades;
|
·
|
utilization
levels and dayrates for offshore oil and gas drilling
rigs;
|
·
|
the
availability and cost of insurance, and the risks associated with
self-insurance, covering drilling
rigs;
|
·
|
regulatory
issues affecting natural gas transmission, including ratemaking
and other
proceedings particularly affecting our gas transmission
subsidiaries;
|
·
|
the
ability of Texas Gas and Gulf South to renegotiate, extend or replace
existing customer contracts on favorable
terms;
|
·
|
the
successful development and projected cost of planned expansion
projects
and investments; and
|
·
|
the
development of additional natural gas reserves and the completion
of
projected new liquefied natural gas facilities and expansion of
existing
facilities.
|
·
|
general
economic and business conditions;
|
·
|
changes
in financial markets (such as interest rate, credit, currency,
commodities
and equities markets) or in the value of specific
investments;
|
·
|
changes
in domestic and foreign political, social and economic conditions,
including the impact of the global war on terrorism, the war in
Iraq, the
future outbreak of hostilities and future acts of
terrorism;
|
·
|
the
economic effects of the September 11, 2001 terrorist attacks, other
terrorist attacks and the war in
Iraq;
|
·
|
potential
changes in accounting policies by the Financial Accounting Standards
Board, the SEC or regulatory agencies for any of our subsidiaries’
industries which may cause us or our subsidiaries to revise their
financial accounting and/or disclosures in the future, and which
may
change the way analysts measure our and our subsidiaries’
business or
financial performance;
|
·
|
the
impact of regulatory initiatives and compliance with governmental
regulations, judicial rulings and jury
verdicts;
|
·
|
the
results of financing efforts;
|
·
|
the
closing of any contemplated transactions and agreements;
and
|
·
|
the
outcome of pending litigation.
|
Category
of risk exposure:
|
Fair
Value Asset (Liability)
|
Market
Risk
|
|||||||||||
March
31,
|
December
31,
|
March
31,
|
December
31,
|
||||||||||
2007
|
2006
|
2007
|
2006
|
||||||||||
(In
millions)
|
|||||||||||||
Equity
markets (1):
|
|||||||||||||
Equity
securities (a)
|
$
|
729.2
|
$
|
685.5
|
$
|
(182.0
|
)
|
$
|
(171.0
|
)
|
|||
Futures -
short
|
72.0
|
||||||||||||
Options
- purchased
|
22.4
|
25.9
|
4.0
|
(1.0
|
)
|
||||||||
- written
|
(3.8
|
)
|
(13.0
|
)
|
(1.0
|
)
|
9.0
|
||||||
Warrants
|
0.3
|
0.4
|
|||||||||||
Short
sales
|
(60.5
|
)
|
(61.9
|
)
|
15.0
|
15.0
|
|||||||
Limited
partnership investments
|
357.5
|
343.2
|
(29.0
|
)
|
(27.0
|
)
|
|||||||
Interest
rate (2):
|
|||||||||||||
Futures
- long
|
1.0
|
||||||||||||
Futures
- short
|
(49.0
|
)
|
(29.0
|
)
|
|||||||||
Interest
rate swaps - short
|
21.0
|
||||||||||||
Interest
rate swaps - long
|
(0.5
|
)
|
(4.0
|
)
|
|||||||||
Fixed
maturities - long
|
626.8
|
1,921.7
|
24.0
|
(38.0
|
)
|
||||||||
Short-term
investments
|
4,481.7
|
4,385.5
|
|||||||||||
Other
derivatives
|
2.2
|
(2.0
|
)
|
9.0
|
|||||||||
Commodities
(3):
|
|||||||||||||
Options
- purchased
|
0.5
|
(1.0
|
)
|
||||||||||
- written
|
(0.1
|
)
|
1.0
|
Note:
|
The
calculation of estimated market risk exposure is based on assumed
adverse
changes in the underlying reference price or index of (1) a decrease
in
equity prices of 25%, (2) a decrease in interest rates of 100 basis
points
at March 31, 2007 and an increase in interest rates of 100 basis
points at
December 31, 2006 and (3) an increase in commodity prices of 20%.
Adverse
changes on options which differ from those presented above would
not
necessarily result in a proportionate change to the estimated market
risk
exposure.
|
(a)
|
A
decrease in equity prices of 25% would result in market risk amounting
to
$(163.0) and $(162.0) at March 31, 2007 and December 31, 2006,
respectively. This market risk would be offset by decreases in
liabilities
to customers under variable insurance
contracts.
|
Category
of risk exposure:
|
Fair
Value Asset (Liability)
|
Market
Risk
|
|||||||||||
March
31,
|
December
31,
|
March
31,
|
December
31,
|
||||||||||
2007
|
2006
|
2007
|
2006
|
||||||||||
(In
millions)
|
|||||||||||||
Equity
markets (1):
|
|||||||||||||
Equity
securities:
|
|||||||||||||
General
accounts (a)
|
$
|
607.1
|
$
|
597.0
|
$
|
(152.0
|
)
|
$
|
(149.0
|
)
|
|||
Separate
accounts
|
41.7
|
41.4
|
(10.0
|
)
|
(10.0
|
)
|
|||||||
Limited
partnership investments
|
1,910.6
|
1,817.3
|
(151.0
|
)
|
(143.0
|
)
|
|||||||
Interest
rate (2):
|
|||||||||||||
Fixed
maturities (a)(b)
|
34,519.8
|
35,648.0
|
(1,930.0
|
)
|
(1,959.0
|
)
|
|||||||
Short-term
investments (a)
|
10,139.5
|
8,436.9
|
(6.0
|
)
|
(5.0
|
)
|
|||||||
Other
invested assets
|
15.9
|
21.3
|
|||||||||||
Other
derivative securities
|
8.3
|
4.6
|
201.0
|
190.0
|
|||||||||
Separate
accounts (a):
|
|||||||||||||
Fixed
maturities
|
429.7
|
433.1
|
(21.0
|
)
|
(21.0
|
)
|
|||||||
Short-term
investments
|
27.2
|
21.4
|
|||||||||||
Debt
|
(5,189.0
|
)
|
(5,443.0
|
)
|
Note:
|
The
calculation of estimated market risk exposure is based on assumed
adverse
changes in the underlying reference price or index of (1) a decrease
in
equity prices of 25% and (2) an increase in interest rates of 100
basis
points.
|
(a)
|
Certain
securities are denominated in foreign currencies. An assumed 20%
decline
in the underlying exchange rates would result in an aggregate foreign
currency exchange rate risk of $(264.0) and $(283.0) at March 31,
2007 and
December 31, 2006, respectively.
|
(b)
|
Certain
fixed maturities positions include options embedded in convertible
debt
securities. A decrease in underlying equity prices of 25% would
result in
market risk amounting to $(257.0) and $(227.0) at March 31, 2007
and
December 31, 2006, respectively.
|
Period
|
(a)
Total number
of
shares purchased
|
(b)
Average
price
paid per share
|
(c)
Total number of shares purchased as
part
of publicly announced plans or programs
|
(d)
Maximum number of shares (or approximate dollar value)
of
shares that may yet be purchased under the plans or programs (in
millions)
|
||||
January
1, 2007 -
|
||||||||
January
31, 2007
|
754,600
|
$41.06
|
N/A
|
N/A
|
||||
February
1, 2007 -
|
||||||||
February
28, 2007
|
2,239,149
|
43.64
|
N/A
|
N/A
|
||||
March
1, 2007
|
||||||||
March
31, 2007
|
4,267,700
|
43.42
|
N/A
|
N/A
|
Exhibit | |
Description
of Exhibit
|
Number
|
Loews
Corporation 2000 Stock Option Plan as amended through April 10,
2007
|
10.1*
|
Carolina
Group 2002 Stock Option Plan as amended through April 10,
2007
|
10.2*
|
Certification
by the Chief Executive Officer of the Company pursuant to Rule
13a-14(a)
and Rule 15d-14(a)
|
31.1*
|
Certification
by the Chief Financial Officer of the Company pursuant to Rule
13a-14(a)
and Rule 15d-14(a)
|
31.2*
|
Certification
by the Chief Executive Officer of the Company pursuant to 18 U.S.C.
Section 1350 (as adopted by Section 906 of the Sarbanes-Oxley Act
of
2002)
|
32.1*
|
Certification
by the Chief Financial Officer of the Company pursuant to 18 U.S.C.
Section 1350 (as adopted by Section 906 of the Sarbanes-Oxley Act
of
2002)
|
32.2*
|
Pending
Tobacco Litigation, incorporated by reference to Exhibit 99.01
to
Registrant’s Report on Form 10-K for the year ended December 31,
2006
|
99.1
|
|
LOEWS
CORPORATION
|
|
|
(Registrant)
|
|
|
||
|
||
|
||
Dated: April
30, 2007
|
By:
|
/s/
Peter W. Keegan
|
|
PETER
W. KEEGAN
|
|
|
Senior
Vice President and
|
|
Chief
Financial Officer
|
||
(Duly
authorized officer
|
||
and
principal financial
|
||
officer)
|
Section
1.
|
General
|
Section
2.
|
Options
|
(a)
|
Unless
otherwise provided by the Committee at the time of grant or thereafter,
each Option shall vest and become exercisable in four equal annual
installments beginning on the first anniversary of the date of grant,
and
shall thereafter remain exercisable during the
Term.
|
(b)
|
Unless
otherwise provided by the Committee at the time of grant or thereafter,
the Term of each Option shall end on the earliest of (1) the date
on which
such Option has been exercised in full, (2) the date on which the
Participant experiences a Termination for Cause or a voluntary
Termination, (3) the one-year anniversary of the date on which the
Participant experiences a Termination due to death or Disability,
(4) the
three-year anniversary of the date on which the Participant experiences
a
Termination due to such person’s Retirement, and (5) the 90th day after
the Participant experiences a Termination for any other reason; provided,
that in no event may the Term exceed ten (10) years from the date
of grant
of the Option. Except as otherwise determined by the Committee at
the time
of grant or thereafter, upon the occurrence of a Termination of a
Participant for any reason, the Term of all outstanding Options held
by
the Participant that are unvested as of the date of such Termination
shall
thereupon end and such unvested Options
shall
|
(c)
|
An
Option may be exercised and the underlying shares purchased in accordance
with this Section 2 at any time after the Option with respect to
those
shares vests and before the expiration of the Term. To exercise an
Option,
the Participant shall give written notice to the Company stating
the
number of shares with respect to which the Option is being
exercised.
|
(d)
|
The
full Exercise Price for shares of Stock purchased upon the exercise
of any
Option shall be paid at the time of such exercise (except that, in
the
case of an exercise arrangement approved by the Committee and described
in
the last sentence of this paragraph (d), payment may be made as soon
as
practicable after the exercise). The Exercise Price shall be payable
by
check, or such other instrument as the Committee may accept. The
Committee
may permit a Participant to elect to pay the Exercise Price upon
the
exercise of an Option by irrevocably authorizing a third party to
sell
shares of Stock (or a sufficient portion of the shares) acquired
upon
exercise of the Option and remit to the Company a sufficient portion
of
the sale proceeds to pay the entire Exercise Price and any tax withholding
resulting from such exercise. In the case of any ISO such permission
must
be provided for at the time of grant and set forth in an Award
Certificate. In addition, if approved by the Committee, payment,
in full
or in part, may also be made in the form of unrestricted Mature Shares,
based on the Fair Market Value of the Mature Shares on the date the
Option
is exercised; provided, however, that, in the case of an ISO the
right to
make a payment in such Mature Shares may be authorized only at the
time
the Option is granted.
|
(a)
|
The
shares of Stock with respect to which Options and Stock Appreciation
Rights may be granted under the Plan shall be shares currently authorized
but unissued or currently held or subsequently acquired by the Company
as
treasury shares, including shares purchased in the open market or
in
private transactions.
|
(b)
|
Subject
to the following provisions of this subsection 4.2, the maximum number
of
shares of Stock that may be delivered to Participants and their
beneficiaries under the Plan shall be 12,000,000 shares of Stock
(as
adjusted to reflect stock splits effected March 2001 and May
2006).
|
(c)
|
To
the extent any shares of Stock covered by an Option are not delivered
to a
Participant or beneficiary because the Option is forfeited or canceled,
such shares shall not be deemed to have been delivered for purposes
of
determining the maximum number of shares of Stock available for delivery
under the Plan.
|
(d)
|
Subject
to paragraph 4.2(e), the maximum number of shares that may be covered
by
Options and/or Stock Appreciation Rights granted to any one individual
during any one calendar year period shall be 1,200,000 shares (as
adjusted
to reflect stock splits effected March 2001 and May
2006).
|
(e)
|
In
the event of a corporate transaction involving the Company (including,
without limitation, any stock dividend, stock split, extraordinary
cash
dividend, recapitalization, reorganization, merger, consolidation,
split-up, spin-off, combination or exchange of shares), the Committee
shall make adjustments to preserve the benefits or potential benefits
of
the Plan and outstanding Options and/or Stock Appreciation Rights.
Action
by the Committee may include: (i) adjustment of the number and kind
of
shares which may be delivered under the Plan; (ii) adjustment of
the
number and kind of shares referred to in Sections 4.2 (b) and (d);
(iii)
adjustment of the number and kind of shares subject to outstanding
Options
and Stock Appreciation Rights; (iv) adjustment of the Exercise Price
of
outstanding Options and Stock Appreciation Rights; (v) settlement
in cash
or Stock in an amount equal to the excess of the value of the Stock
subject to such Options and Stock Appreciation Rights over the aggregate
Exercise Price (as determined by the Committee)
of
|
(a)
|
Notwithstanding
any other provision of the Plan, the Company shall have no liability
to
deliver any shares of Stock under the Plan or make any other distribution
of benefits under the Plan unless such delivery or distribution would
comply with all applicable laws (including, without limitation, the
requirements of the Securities Act of 1933 and Code Section 409A),
and the
applicable requirements of any securities exchange or similar
entity.
|
(b)
|
To
the extent that the Plan provides for issuance of stock certificates
to
reflect the issuance of shares of Stock, the issuance may be effected
on a
non-certificated basis, to the extent not prohibited by applicable
law or
the applicable rules of any stock
exchange.
|
(a)
|
It
is the intention of the Company that no grant of Options or Stock
Appreciation Rights shall be “deferred compensation” subject to Code
Section 409A, unless and to the extent that the Committee specifically
determines otherwise as provided below, and the Plan and the terms
and
conditions of all grants of Options and Stock Appreciation Rights
shall be
interpreted accordingly.
|
(b)
|
The
terms and conditions governing any grants of Options and Stock
Appreciation Rights that the Committee determines will be subject
to Code
Section 409A, including any rules for elective or mandatory deferral
of
the delivery of cash pursuant thereto, shall be set forth in writing,
and
shall comply in all respects with Code Section
409A.
|
(a)
|
Neither
a Participant nor any other person shall, by reason of participation
in
the Plan, acquire any right in or title to any assets, funds or property
of the Company whatsoever, including, without limitation, any specific
funds, assets, or other property which the Company, in its
sole
|
(b)
|
The
Plan does not constitute a contract of employment, and selection
as a
Participant will not give any Participant the right to be retained
in the
employ of, or as a director or consultant to, the Company or any
Subsidiary, nor any right or claim to any benefit under the Plan,
unless
such right or claim has specifically accrued under the terms of the
Plan.
|
(a)
|
Subject
to the provisions of the Plan, the Committee will have the authority
and
discretion to select from among the Eligible Grantees those persons
who
shall receive Options and/or Stock Appreciation Rights, to determine
the
grant date of, the number of shares subject to and the Exercise Price
of
those Options and Stock Appreciation Rights, to establish all other
terms
and conditions of such Options and Stock Appreciation Rights, and
(subject
to the restrictions imposed by Section 6) to cancel or suspend Options
and
Stock Appreciation Rights.
|
(b)
|
The
Committee will have the authority and discretion to interpret the
Plan, to
establish, amend, and rescind any rules and regulations relating
to the
Plan, and to make all other determinations that may be necessary
or
advisable for the administration of the
Plan.
|
(c)
|
Any
interpretation of the Plan by the Committee and any decision made
by it
under the Plan is final and binding on all
persons.
|
(d)
|
In
controlling and managing the operation and administration of the
Plan, the
Committee shall take action in a manner that conforms to the articles
and
by-laws of the Company, and applicable state corporate
law.
|
(a)
|
Award
Certificate. The
term “Award Certificate” shall mean a written certificate setting forth
the terms and conditions of an Option or Stock Appreciation Right,
in such
form as the Committee may from time to time
prescribe.
|
(b)
|
Board. The
term “Board” means the Board of Directors of the
Company.
|
(c)
|
Cause. The
term “Cause” shall have the meaning set forth in the employment or
engagement agreement between a Participant and the Company or any
Subsidiary thereof, if such an agreement exists and contains a definition
of Cause; otherwise Cause shall mean (1) conviction of the Participant
for
committing a felony under Federal law or the law of the state in
which
such action occurred, (2) dishonesty in the course of fulfilling
a
Participant’s employment, engagement or directorial duties, (3) willful
and deliberate failure on the part of a Participant to perform the
Participant’s employment, engagement or directorial duties in any material
respect or (4) such other events as shall be determined in good faith
by
the Committee. The Committee shall, unless otherwise provided in
an Award
Certificate or employment agreement with the Participant, have the
sole
discretion to determine whether Cause exists, and its determination
shall
be final.
|
(d)
|
Code. The
term “Code” means the Internal Revenue Code of 1986, as amended, the
Treasury Regulations thereunder and other relevant interpretive guidance
issued by the Internal Revenue Service or the Treasury Department.
Reference to any specific section of the Code shall be deemed to
include
such regulations and guidance, as well as any successor provision
of the
Code.
|
(e)
|
Committee. The
term “Committee” shall have the meaning set forth in Section
5.1.
|
(f)
|
Company. The
term “Company” shall have the meaning set forth in Section
1.1.
|
(g)
|
Designated
Beneficiary. The
term “Designated Beneficiary” shall have the meaning set forth in Section
4.10.
|
(h)
|
Disability. The
term “Disability” shall mean, unless otherwise provided by the Committee,
(1) “Disability” as defined in any individual Award Certificate to which
the Participant is a party, or (2) if there is no such Award Certificate
or it does not define “Disability,” permanent and total disability as
determined under the Company’s long-term disability plan applicable to the
Participant.
|
(i)
|
Effective
Date. The
term “Effective Date” shall have the meaning set forth in Section
4.1.
|
(j)
|
Eligible
Grantee. The
term “Eligible Grantee” shall mean any individual who is employed on a
full-time or part-time basis, or who serves as a consultant to, by
the
Company or a Subsidiary and
|
(k)
|
Exercise
Price. The
term “Exercise Price” shall have the meaning set forth in Section 2.3 and
3.3 as applicable.
|
(l)
|
Fair
Market Value. The
“Fair Market Value” of a share of Stock shall be, as of any given date,
the mean between the highest and lowest reported sales prices on
the
immediately preceding date (or, if there are no reported sales on
such
immediately preceding date, on the last date prior to such date on
which
there were sales) of the Stock on the New York Stock Exchange Composite
Tape or, if not listed on such exchange, on any other national securities
exchange on which the Stock is listed or on NASDAQ. If there is no
regular
public trading market for such Stock, the Fair Market Value of the
Stock
shall be determined by the Committee in good
faith.
|
(m)
|
Free-Standing
SAR. The
term “Free-Standing SAR” shall have the meaning set forth in Section
3.1.
|
(n)
|
ISO. The
term “ISO” shall have the meaning set forth in Section
2.2.
|
(o)
|
Mature
Shares. The
term “Mature Shares” shall mean shares of Stock that have been owned by
the Participant in question for at least six
months.
|
(p)
|
NQO. The
term “NQO” shall have the meaning set forth in Section
2.2.
|
(q)
|
Option. The
term “Option” shall have the meaning set forth in Section
2.2.
|
(r)
|
Plan. The
term “Plan” shall have the meaning set forth in Section
1.1.
|
(s)
|
Retirement. The
term “Retirement” shall mean retirement from active employment with the
Company pursuant to any retirement plan or program of the Company
or any
Subsidiary in which the Participant participates. A Termination by
a
consultant or non-employee director shall in no event be considered
a
Retirement.
|
(t)
|
Stock. The
term “Stock” shall mean shares of common stock of the
Company.
|
(u)
|
Stock
Appreciation Right. The
term “Stock Appreciation Right “ shall have the meaning set forth in
Section 3.1.
|
(v)
|
Subsidiary. The
term “Subsidiary” means any business or entity in which at any relevant
time the Company holds at least a 50% equity (voting or non-voting)
interest.
|
(w)
|
Tandem
SAR. The
term “Tandem SAR” shall have the meaning set forth in Section
3.1.
|
(x)
|
Term. The
term “Term” shall mean the period beginning on the date of grant of an
Option or Stock Appreciation Right and ending on the date the Option
or
Stock Appreciation Right expires pursuant to the Plan and the relevant
Award Certificate.
|
(y)
|
Termination. A
Participant shall be considered to have experienced a Termination
if he or
she ceases, for any reason, to be an employee, consultant or non-employee
director of the Company or any of its Subsidiaries, including, without
limitation, as a result of the fact that the entity by which he or
she is
employed or engaged or of which he or she is a director has ceased
to be
affiliated with the Company.
|
Section
1.
|
General
|
Section
2.
|
Options
|
(a)
|
Unless
otherwise provided by the Committee at the time of grant or thereafter,
each Option shall vest and become exercisable in four equal annual
installments beginning on the first anniversary of the date of grant,
and
shall thereafter remain exercisable during the Option
Term.
|
(b)
|
Unless
otherwise provided by the Committee at the time of grant or thereafter,
the Option Term of each Option shall end on the earliest of (1) the
date
on which such Option has been exercised in full, (2) the date on
which the
Participant experiences a Termination for Cause or a voluntary
Termination, (3) the one-year anniversary of the date on which the
Participant experiences a Termination due to death or Disability,
(4) the
three-year anniversary of the date on which the Participant experiences
a
Termination due to such person’s Retirement, and (5) the 90th day after
the Participant experiences a Termination for any other reason;
provided,
that in no event may the Option Term exceed ten (10) years from the
date
of grant of the Option. Except as otherwise determined by the Committee
at
the time of grant or thereafter, upon the occurrence of a Termination
of a
Participant for any reason, the Option Term of all outstanding Options
held by the Participant that are unvested as of the date of such
Termination shall thereupon end and such unvested Options shall be
forfeited immediately; provided,
however,
that the Committee may, in its sole discretion, accelerate the vesting
of
any Option and/or extend the exercise period of any Option (but not
beyond
the ten-year anniversary of the grant
date).
|
(c)
|
An
Option may be exercised and the underlying shares purchased in accordance
with this Section 2 at any time after the Option with respect to
those
shares vests and before the expiration of the Option Term. To exercise
an
Option, the Participant shall give written notice to the Company
stating
the number of shares with respect to which the Option is being
exercised.
|
(d)
|
The
full Exercise Price for shares of Stock purchased upon the exercise
of any
Option shall be paid at the time of such exercise (except that, in
the
case of an exercise arrangement approved by the Committee and described
in
the last sentence of this paragraph (d), payment may be made as soon
as
practicable after the exercise). The Exercise Price shall be payable
by
check, or such other instrument as the Committee may accept. The
Committee
may permit a Participant to elect to pay the Exercise Price upon
the
exercise of an Option by irrevocably authorizing a third party to
sell
shares of Stock (or a sufficient portion of the shares) acquired
upon
exercise of the Option and remit to the Company a sufficient portion
of
the sale proceeds to pay the entire Exercise Price and any tax withholding
resulting from such exercise. In the case of any ISO such permission
must
be provided for at the time of grant and set forth in an Award
Certificate. In addition, if approved by the Committee, payment,
in full
or in part, may also be made in the form of unrestricted Mature Shares,
based on the Fair Market Value of the Mature Shares on the date the
Option
is exercised; provided,
however,
that, in the case of an ISO the right to make a payment in such Mature
Shares may be authorized only at the time the Option is
granted.
|
(a)
|
The
shares of Stock with respect to which Options and Stock Appreciation
Rights may be granted under the Plan shall be shares currently authorized
but unissued or currently held or subsequently acquired by the Company
as
treasury shares, including shares purchased in the open market or
in
private transactions.
|
(b)
|
Subject
to the following provisions of this subsection 4.2, the maximum number
of
shares of Stock that may be delivered to Participants and their
beneficiaries under the Plan shall be 1,500,000 shares of
Stock.
|
(c)
|
To
the extent any shares of Stock covered by an Option are not delivered
to a
Participant or beneficiary because the Option is forfeited or canceled,
such shares shall not be deemed to have been delivered for purposes
of
determining the maximum number of shares of Stock available for delivery
under the Plan.
|
(d)
|
Subject
to paragraph 4.2(e), the maximum number of shares that may be covered
by
Options, and/or Stock Appreciation Rights granted to any one individual
during any one calendar year period shall be 200,000
shares.
|
(e)
|
In
the event of a corporate transaction involving the Stock and/or the
Company (including, without limitation, any stock dividend, stock
split,
extraordinary cash dividend, recapitalization, reorganization, merger,
consolidation, split-up, spin-off, combination or exchange of shares),
the
Committee shall make adjustments to preserve the benefits or potential
benefits of the Plan and outstanding Options and/or Stock Appreciation
Rights. Action by the Committee may include: (i) adjustment of the
number
and kind of shares which may be delivered under the Plan; (ii) adjustment
of the number and kind of shares referred to in Sections 4.2 (b)
and (d);
(iii) adjustment of the number and kind of shares subject to outstanding
Options and Stock Appreciation Rights; (iv) adjustment of the Exercise
Price of outstanding Options and Stock Appreciation Rights; (v) settlement
in cash or Stock in an amount equal to the excess of the value of
the
Stock subject to such Option and Stock Appreciation Rights over the
aggregate Exercise Price (as determined by the Committee) of such
Options
and Stock Appreciation Rights; and (vi) any other adjustments that
the
Committee determines to be equitable. The Committee shall make all
such
adjustments, and its determination as to what adjustments shall be
made,
and the extent thereof, shall be
final.
|
(a)
|
Notwithstanding
any other provision of the Plan, the Company shall have no liability
to
deliver any shares of Stock under the Plan or make any other distribution
of benefits under the Plan unless such delivery or distribution would
comply with all applicable laws (including, without limitation, the
requirements of the Securities Act of 1933 and Code Section 409(A)),
and
the applicable requirements of any securities exchange or similar
entity.
|
(b)
|
To
the extent that the Plan provides for issuance of stock certificates
to
reflect the issuance of shares of Stock, the issuance may be effected
on a
non-certificated basis, to the extent not prohibited by applicable
law or
the applicable rules of any stock
exchange.
|
(a)
|
It
is the intention of the Company that no grant of Options or Stock
Appreciation Rights shall be “deferred compensation” subject to Code
Section 409A, unless and to the extent that the Committee specifically
determines otherwise as provided below, and the Plan and the terms
and
conditions of all grants of Options and Stock Appreciation Rights
shall be
interpreted accordingly.
|
(b)
|
The
terms and conditions governing any grants of Options and Stock
Appreciation Rights that the Committee determines will be subject
to Code
Section 409A, including any rules for elective or mandatory deferral
of
the delivery of cash pursuant thereto, shall be set forth in writing,
and
shall comply in all respects with Code Section
409A.
|
(a)
|
Neither
a Participant nor any other person shall, by reason of participation
in
the Plan, acquire any right in or title to any assets, funds or property
of the Company whatsoever, including, without limitation, any specific
funds, assets, or other property which the Company, in its sole
discretion, may set aside in anticipation of a liability under the
Plan. A
Participant shall have only a contractual right to the amounts, if
any,
payable under the Plan, unsecured by any assets of the Company, and
nothing contained in the Plan shall constitute a guarantee that the
assets
of the Company shall be sufficient to pay any benefits to any
person.
|
(b)
|
The
Plan does not constitute a contract of employment, and selection
as a
Participant will not give any Participant the right to be retained
in the
employ of, or as a director or consultant to, the Company or any
Subsidiary, nor any right or claim to any benefit under the Plan,
unless
such right or claim has specifically accrued under the terms of the
Plan.
|
(a)
|
Subject
to the provisions of the Plan, the Committee will have the authority
and
discretion to select from among the Eligible Grantees those persons
who
shall receive Options and/or Stock Appreciation Rights, to determine
the
grant date of, the number of shares subject to and the Exercise Price
of
those Options and Stock Appreciation Rights, to establish all other
terms
and conditions of such Options and Stock Appreciation Rights, and
(subject
to the restrictions imposed by Section 6) to cancel or suspend Options
and
Stock Appreciation Rights.
|
(b)
|
The
Committee will have the authority and discretion to interpret the
Plan, to
establish, amend, and rescind any rules and regulations relating
to the
Plan, and to make all other determinations that may be necessary
or
advisable for the administration of the
Plan.
|
(c)
|
Any
interpretation of the Plan by the Committee and any decision made
by it
under the Plan is final and binding on all
persons.
|
(d)
|
In
controlling and managing the operation and administration of the
Plan, the
Committee shall take action in a manner that conforms to the charter
and
by-laws of the Company, and applicable state corporate
law.
|
(a)
|
Award
Certificate. The
term “Award Certificate” shall mean a written certificate setting forth
the terms and conditions of an Option or Stock Appreciation Right,
in such
form as the Committee may from time to time
prescribe.
|
(b)
|
Board. The
term “Board” means the Board of Directors of the
Company.
|
(c)
|
Carolina
Group. The
term “Carolina Group” shall have the meaning set forth in the Company’s
Restated Certificate of Incorporation, as amended from time to
time.
|
(d)
|
Cause. The
term “Cause” shall have the meaning set forth in the employment or
engagement agreement between a Participant and Lorillard, Inc. or
its
subsidiaries or any company attributed to the Carolina Group in the
future, if such an agreement exists and contains a definition of
Cause;
otherwise Cause shall mean (1) conviction of the Participant for
committing a felony under Federal law or the law of the state in
which
such action occurred, (2) dishonesty in the course of fulfilling
a
Participant’s employment, engagement or directorial duties, (3) willful
and deliberate failure on the part of a Participant to perform the
Participant’s employment, engagement or directorial duties in any material
respect or (4) such other events as shall be determined in good faith
by
the Committee. The Committee shall, unless otherwise provided in
the Award
Certificate or an employment agreement with the Participant, have
the sole
discretion to determine whether Cause exists, and its determination
shall
be final.
|
(e)
|
Code. The
term “Code” means the Internal Revenue Code of 1986, as amended, the
Treasury Regulations thereunder and other relevant interpretive guidance
issued by the Internal Revenue Service or the Treasury Department.
Reference to any specific section of the Code shall be deemed to
include
such regulations and guidance, as well as any successor provision
of the
Code.
|
(f)
|
Committee. The
term “Committee” shall have the meaning set forth in Section
5.1.
|
(g)
|
Company. The
term “Company” shall have the meaning set forth in Section
1.1.
|
(h)
|
Designated
Beneficiary. The
term “Designated Beneficiary” shall have the meaning set forth in Section
4.10.
|
(i)
|
Disability. The
term “Disability” shall mean, unless otherwise provided by the Committee,
(1) “Disability” as defined in any individual Award Certificate to which
the Participant is a party, or (2) if there is no such Award Certificate
or it does not define “Disability,” permanent and total disability as
determined under the long-term disability plan of Lorillard, Inc.
or any
of its subsidiaries or any company attributed to the Carolina Group
in the
future applicable to the
Participant.
|
(j)
|
Effective
Date. The
term “Effective Date” shall have the meaning set forth in Section
4.1.
|
(k)
|
Eligible
Grantee. The
term “Eligible Grantee” shall mean any individual who is employed on a
full-time or part-time basis by, or who serves as a consultant to,
Lorillard, Inc. or any of its subsidiaries or any company attributed
to
the Carolina Group in the future and any non-employee director of
Lorillard, Inc. or any of its subsidiaries or any company attributed
to
the Carolina Group in the future. An Option or Stock Appreciation
Right
may be granted to an individual in connection with such individual’s
hiring or engagement prior to the date the individual first performs
services for Lorillard, Inc. or any of its subsidiaries or any company
attributed to the Carolina Group in the future; provided
that the individual will be an Eligible Grantee upon his hiring or
engagement; and further provided
that such Options and/or Stock Appreciation Rights shall not become
vested
prior to the date the individual first performs such
services.
|
(l)
|
Exercise
Price. The
term “Exercise Price” shall have the meaning set forth in Section 2.3 and
3.3 as applicable.
|
(m)
|
Fair
Market Value. The
“Fair Market Value” of a share of Stock shall be, as of any given date,
the mean between the highest and lowest reported sales prices during
normal trading hours on the immediately preceding date (or, if there
are
no reported sales on such immediately preceding date, on the last
date
prior to such date on which there were sales) of the Stock on the
New York
Stock Exchange Composite Tape or, if not listed on such exchange,
on any
other national securities exchange on which the Stock is listed or
on
NASDAQ. If there is no regular public trading market for such Stock,
the
Fair Market Value of the Stock shall be determined by the Committee
in
good faith.
|
(n)
|
Free-Standing
SAR. The
term “Free-Standing SAR” shall have the meaning set forth in Section
3.1.
|
(o)
|
ISO. The
term “ISO” shall have the meaning set forth in Section
2.2.
|
(p)
|
Mature
Shares. The
term “Mature Shares” shall mean shares of Stock that have been owned by
the Participant in question for at least six
months.
|
(q)
|
NQO. The
term “NQO” shall have the meaning set forth in Section
2.2.
|
(r)
|
Option. The
term “Option” shall have the meaning set forth in Section
2.2.
|
(s)
|
Plan. The
term “Plan” shall have the meaning set forth in Section
1.1.
|
(t)
|
Retirement. The
term “Retirement” shall mean retirement from active employment with
Lorillard, Inc. or its subsidiaries or any company attributed to
the
Carolina Group in the future pursuant to any retirement plan or program
of
Lorillard, Inc. or its subsidiaries or any company attributed to
the
Carolina Group in the future in which the Participant participates.
A
Termination by a consultant or non-employee director shall in no
event be
considered a Retirement.
|
(u)
|
Stock. The
term “Stock” shall mean shares of Carolina Group stock, par value, $0.01
per share, of the Company.
|
(v)
|
Stock
Appreciation Right. The
term “Stock Appreciation Right” shall have the meaning set forth in
Section 3.1.
|
(w)
|
Subsidiary. The
term “Subsidiary” means any business or entity in which at any relevant
time the Company holds at least a 50% equity (voting or non-voting)
interest.
|
(x)
|
Tandem
SAR. The
term “Tandem SAR” shall have the meaning set forth in Section
3.1.
|
(y)
|
Term. The
term “Term” shall mean the period beginning on the date of grant of an
Option or Stock Appreciation Right and ending on the date the Option
or
Stock Appreciation Right expires pursuant to the Plan and the relevant
Award Certificate.
|
(z)
|
Termination. A
Participant shall be considered to have experienced a Termination
if he or
she ceases, for any reason, to be an employee, consultant or non-employee
director of Lorillard, Inc. or any of its subsidiaries or any company
attributed to the Carolina Group in the future, including, without
limitation, as a result of the fact that the entity by which he or
she is
employed or engaged or of which he or she is a director has ceased
to be
affiliated with Lorillard, Inc. or its subsidiaries or any company
attributed to the Carolina Group in the
future.
|
(a)
|
Designed
such disclosure controls and procedures, or caused such disclosure
controls and procedures to be designed under our supervision, to
ensure
that material information relating to the registrant, including its
consolidated subsidiaries, is made known to us by others within those
entities, particularly during the period in which this report is
being
prepared;
|
(b)
|
Designed
such internal controls over financial reporting, or caused such internal
controls over financial reporting to be designed under our supervision,
to
provide reasonable assurance regarding the reliability of financial
reporting and the preparation of financial statements for external
purposes in accordance with generally accepted accounting
principles;
|
(c)
|
Evaluated
the effectiveness of the registrant’s disclosure controls and procedures
and presented in this report our conclusions about the effectiveness
of
the disclosure controls and procedures, as of the end of the period
covered by this report based on such evaluation;
and
|
(d)
|
Disclosed
in this report any change in the registrant’s internal control over
financial reporting that occurred during the registrant’s most recent
fiscal quarter (the registrant’s fourth fiscal quarter in the case of an
annual report) that has materially affected, or is reasonably likely
to
materially affect, the registrant’s internal control over financial
reporting; and
|
(a)
|
All
significant deficiencies and material weaknesses in the design or
operation of internal control over financial reporting which are
reasonably likely to adversely affect the registrant’s ability to record,
process, summarize and report financial information;
and
|
(b)
|
Any
fraud, whether or not material, that involves management or other
employees who have a significant role in the registrant’s internal control
over financial reporting.
|
Dated: April
30, 2007
|
By:
|
/s/
James S. Tisch
|
JAMES
S. TISCH
|
||
Chief
Executive Officer
|
(a)
|
Designed
such disclosure controls and procedures, or caused such disclosure
controls and procedures to be designed under our supervision, to
ensure
that material information relating to the registrant, including
its
consolidated subsidiaries, is made known to us by others within
those
entities, particularly during the period in which this report is
being
prepared;
|
(b)
|
Designed
such internal controls over financial reporting, or caused such
internal
controls over financial reporting to be designed under our supervision,
to
provide reasonable assurance regarding the reliability of financial
reporting and the preparation of financial statements for external
purposes in accordance with generally accepted accounting
principles;
|
(c)
|
Evaluated
the effectiveness of the registrant’s disclosure controls and procedures
and presented in this report our conclusions about the effectiveness
of
the disclosure controls and procedures, as of the end of the period
covered by this report based on such evaluation;
and
|
(d)
|
Disclosed
in this report any change in the registrant’s internal control over
financial reporting that occurred during the registrant’s most recent
fiscal quarter (the registrant’s fourth fiscal quarter in the case of an
annual report) that has materially affected, or is reasonably likely
to
materially affect, the registrant’s internal control over financial
reporting; and
|
(a)
|
All
significant deficiencies and material weaknesses in the design
or
operation of internal control over financial reporting which are
reasonably likely to adversely affect the registrant’s ability to record,
process, summarize and report financial information;
and
|
(b)
|
Any
fraud, whether or not material, that involves management or other
employees who have a significant role in the registrant’s internal control
over financial reporting.
|
Dated: April
30, 2007
|
By:
|
/s/Peter
W. Keegan
|
PETER
W. KEEGAN
|
||
Chief
Financial Officer
|
Dated: April
30, 2007
|
By:
|
/s/
James S. Tisch
|
JAMES
S. TISCH
|
||
Chief
Executive Officer
|
Dated: April
30, 2007
|
By:
|
/s/
Peter W. Keegan
|
PETER
W. KEEGAN
|
||
Chief
Financial Officer
|